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FSP Section 21,000
CHECKLISTS AND ILLUSTRATIVE
FINANCIAL STATEMENTS FOR HEALTH
CARE PROVIDERS
.01 The checklists and illustrative financial statements included in this section have been developed by the
staff of the Technical Information Division of the AICPA as nonauthoritative technical practice aids. Readers
should be aware of the following:
•

The checklists and illustrative financial statements are "tools" and in no way represent official positions
or pronouncements of the AICPA.

•

The checklists and illustrative financial statements have been updated through FASB Statement No. 115,
FASB Interpretation No. 40, FASB Technical Bulletin No. 94-1, AICPA Statement of Position No. 93-8,
AICPA Statement on Auditing Standards No. 72, AICPA Statement on Standards for Accounting and
Review Services No. 7, and AICPA Audit and Accounting Guide, Audits of Providers of Health Care
Services (with conforming changes as of May 1, 1993). The illustrative financial statements do not
include disclosures for FASB Statement Nos. 106, 107, 112, 114 or 115. The checklists and illustrative
financial statements should be modified, as appropriate, for subsequent pronouncements. In determining
the applicability of a pronouncement, its effective date should also be considered.

•

In June 1993, the FASB issued Statements of Financial Accounting Standards (SFAS) No. 116, Account
ing for Contributions Received and Contributions Made, and No. 117, Financial Statements of Not-forProfit Organizations. SFAS No. 116 changes the accounting for contributions as presently set forth in
SOP 78-10 and in the audits of Providers of Health Care Services Guide. SFAS No. 117 establishes
standards for not-for-profit organizations general purpose external financial statements. SFAS Nos. 116
and 117 are effective for financial statements issued for fiscal years beginning after December 15, 1994,
except for organizations with less than $5 million in total assets and less than $1 million in annual
expenses. For those organizations, the Statements are effective for fiscal years beginning after December
15, 1995. Earlier application is encouraged.

•

These Statements are not reflected in these checklists and illustrative financial statements as few
organizations have adopted these pronouncements at this time. The 1995 edition of these checklists and
illustrative financial statements will be revised to reflect these new pronouncements. Practitioners whose
clients have adopted SFAS Nos. 116 and 117 early should determine the effect of these Statements when
using these checklists and illustrative financial statements.

•

The checklists and illustrative financial statements should be used by, or under the supervision of,
persons having adequate technical training and proficiency in the application of generally accepted
accounting principles, generally accepted auditing standards, and statements on standards for accounting
and review services.

•

The checklists and illustrative financial statements do not represent minimum requirements and do not
purport to be all-inclusive. The referenced standards should be reviewed if clarification is needed to
determine whether the disclosure indicated is required or suggested, and to what extent each disclosure
is relevant to the statements being presented.

.02 Users of the checklists and illustrative financial statements are urged to refer directly to applicable
authoritative pronouncements when appropriate. If you have further questions, call the AICPA Technical Hotline.
Note: This publication was extracted from sections 21,000 to 21,600 of the AICPA Financial Statement Preparation Manual (FSP).
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FSP Section 21,100
Introduction
.01 Health care costs, as well as the number of people requiring health care services, have consistently risen.
As a result, many health care providers are relying more heavily on debt financing to meet capital needs creating a
greater need for accountability to creditors and investors.

.02 Health care entities may be classified by sponsorship or legal structure within three broad categories:
voluntary (not-for-profit), governmental, and investor- (or operator-) owned.

Voluntary (not-for-profit): an entity that operates under the direction of governing boards. Usually
exempt from federal and state income taxes if operated exclusively for religious, charitable, scientific or
educational purposes, the entity may be further classified as community-based, religious affiliated or
university-sponsored.
Governmental: often called public health care entities, the entity is owned and operated by federal, state,
city or county governments or other political subdivisions.
Investor- (or Operator-) Owned: a health care entity that operates as a stock corporation, partnership or
sole proprietorship.

.03 Health care entities include, but are not limited to, the following:

•

Clinics, medical group practices, individual practitioners and practice associations, and other ambulatory
care organizations.

•

Continuing care retirement communities (CCRCs).

•

Health maintenance organizations and similar prepaid health care plans.

•

Home health agencies.

•

Hospitals.

•

Nursing homes that provide skilled, intermediate, and less intensive levels of health care.

•

Parent, holding and other organizations that primarily plan, organize and oversee health care services.

Legislation and Regulation
.04 Significant aspects of health care entity operations are affected by government legislation and regulation
with many states adopting laws governing the granting of licenses, as well as scope of services to be rendered. In
addition, many independent organizations and governmental agencies, including Medicare and Medicaid, evalu
ate programs and services of health care entities to determine compliance with set standards.

Basic Financial Statements
.05 The basic financial statements of not-for-profit and governmental health care entities generally consist of a
balance sheet, statement of revenues and expenses of general funds, statement of changes in fund balances, and a
statement of cash flows of general funds (and restricted funds of governmental entities). The basic financial
statements of investor-owned health care entities are similar to those of other investor-owned entities. Aggregated
(combined fund) and disaggregated (layered fund) balance sheets are acceptable alternatives to reporting financial
position of nonprofit health care entities and governmental hospitals.
3

Structure of the Checklist
.06 In July 1990, the AICPA published the audit and accounting guide entitled Audits of Providers of Health
Care Services (the Guide). The recommendations contained in the Guide and this checklist apply to the separate
financial statements of health care entities that are either (a) investor-owned, (b) not-for-profit or (c) state or local
government-owned users of enterprise fund accounting and reporting. Financial statements of a state or local
governmental health care entity are subject to statements and interpretations of the Governmental Accounting
Standards Board (GASB) as well as to AICPA and Financial Accounting Standards Board (FASB) pronouncements,
as specified by GASB statements and interpretations. This checklist presents fund accounting guidance first. Any
modifications needed to reflect nonfund accounting are presented in brackets immediately after the related fund
accounting guidance.
.07 Not-for-profit health care providers that receive federal financial assistance may be required to have an
audit conducted in accordance with Office of Management and Budget (OMB) Circular A-133, Audits of
Organizations of Higher Education and Other Nonprofit Organizations. Section 21,500 includes a checklist for
auditor's reports for audits performed under OMB Circular A-133.
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FSP Section 21,200
Checklists—General
.01 Many auditors and accountants find it helpful to use checklists as practice aids in the preparation of
financial statements and reports. Some firms have developed their own checklists for internal use and may also
have specialized checklists to meet the needs of their practices, such as checklists for clients in particular industries
or clients that report to the SEC. Some state CPA societies have developed checklists as practice aids that may be
available to other practitioners, as well as to their own members. Some commercial publishers also include
checklists in certain of their publications. However, authoritative literature does not require the use of such
checklists, nor does it prescribe their format or content, which may vary.
.02 Checklists typically consist of a number of brief questions or statements that are accompanied by
references to Statements on Auditing Standards, Statements on Standards for Accounting and Review Services,
Statements of Financial Accounting Standards, Accounting Principles Board Opinions, and Accounting Research
Bulletins. Some checklists also include references to FASB Interpretations, Statements of Position, and the AICPA
Audit and Accounting Guides. The extent of detail included in checklists varies with the judgment of the preparers
on how extensively to refer to and highlight authoritative literature without developing a checklist that is too long
and unwieldy. Accordingly, checklists may serve as convenient memory aids but cannot be used as a substitute for
direct reference to the authoritative literature.
.03 Checklists usually provide for checking off or initialling each question or point to show that it has been
considered. The format used herein is a typical one; it provides for “yes," "no," and "not applicable" answers and
presumes that remarks would be prepared on separate cross-referenced memorandums. Some preparers, however,
prefer to include space for remarks in the body of the checklist, while others prefer alternative checklist formats.
For example, a checklist format may provide for the following set of answers: "not applicable," "not material," "in
statements," and "in notes" (with provisions for indicating a cross-reference to the specific statement caption or
note). Another format may provide for only two answers, "disclosed" and "not applicable." Firms and practition
ers who develop their own checklists should adopt formats that suit their needs and preferences.

.04 Checklists are generally accompanied by caveats that include all of the following points:
•

Use of the checklists requires the exercise of individual professional judgment and may likely require
some modification based on the circumstances of individual engagements.

•

The checklists are not all-inclusive and are not intended to present minimum requirements.

•

Users need to modify the checklists for any pronouncements issued subsequent to those mentioned in
the checklist.

.05 If widespread circulation is expected, the preparers also generally stress the nonauthoritative or unofficial
status of the checklists and disclaim responsibility for the way they may be used.
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FSP Section 21,300
Financial Statements and Notes Checklist
.01 This checklist has been developed by the staff of the Technical Information Division of the AICPA as a
nonauthoritative practice aid.
.02 Explanation of References:

AAG =

AICPA Audit and Accounting Guide, Audits of Providers of Health Care Services (with
conforming changes as of May 1, 1993)

AC =

Reference to section number in FASB Accounting Standards—Current Text

APB =

AICPA Accounting Principles Board Opinion

ARB =

AICPA Accounting Research Bulletin

AU =

Reference to section number in AICPA Professional Standards (vol. 1)

FASBI =

FASB Interpretation

FASCON =

FASB Statement of Financial Accounting Concepts

SAS =

AICPA Statement on Auditing Standards

SFAS =

FASB Statement of Financial Accounting Standards

SOP =

AICPA Statement of Position

TB =

FASB Technical Bulletin

.03 Checklist Questionnaire
Yes

I.

Accounting Principles of Display and Disclosure
A.
1.

Fund Accounting
General funds

a. For classified balance sheets, are assets and liabilities classified as current and
noncurrent, with totals presented for current assets and current liabilities?
[AAG, par. 3.04; ARB 43, Ch. 3A (AC B05.103—.109); SFAS 6, par. 15 (AC
B05.118); TB 79-3 (AC B05.501—.503)]
b. Are agency funds (assets owned by others under agency relationships (such
as patients or physicians) and their related liabilities) reported in the general
funds?

c. Are transactions involving receipt and disbursement of agency funds
excluded from the results of operations?
[AAG, par. 3.06]
d. Is property and equipment used for general operations (and related liabilities)
reported in the general funds?
e. Is property and equipment not used for general operations (such as property
acquired for future expansion or investment purposes) presented as a separate
item in the general funds?
[AAG, pars. 3.07 and 8.06]

2. Donor-restricted funds
7

No

N/A

Yes

a. Is donor-restricted property and equipment (such as real estate investments of
endowment funds) reported in the appropriate donor-restricted fund?
[AAG, pars. 3.07 and 8.07]
b. Are resources restricted by donors for additions to property and equipment
reported in restricted plant replacement and expansion funds?
c. Are plant replacement and expansion funds reported in the statement of
changes in fund balances when expenditures are incurred for the purpose
intended by the donor?
[AAG, par. 3.10]

d. Do "term endowment funds" include resources whose principal may be
expended after the donor-imposed time or after other restrictions are
satisfied?
e. Is all pertinent information about term endowment funds (such as term and
purposes) disclosed in the notes?

f. Are term endowment funds available for unrestricted purposes reported in
the statement of revenues and expenses?

g. Are term endowment funds that became available, but are further restricted
under the term endowment provisions, shown as a reclassification to the
appropriate donor-restricted fund in the statement of changes in fund
balances?
[AAG, par. 3.11]
h. Do endowment funds include resources whose principal may not be
expended?
[AAG, par. 3.13]

8.

Donated Funds Held in Trust

1. If donated resources are held in a trust (by an independent trustee), of which the
provider is not the remainderman:

a. Are they excluded from the balance sheet?

b. Is their existence disclosed?
[AAG, par. 3.14]

2. Is disclosure considered of the right to future income and the principal held in
trust?
3. If the provider received a distribution, is it reported in accordance with the terms
of the trust or agreement with the trustee?
[AAG, par. 3.15]

4. If the provider is the remainderman, are the donated funds reported as assets
(depending on the terms of the trust document)?
[AAG, par. 3.16]
C.

Financial Statements

1. For not-for-profit and governmental providers, do the basic financial statements
include:
a. A balance sheet?

b. A statement of revenues and expenses of general funds?

c. A statement of changes in fund balances?
d. A statement of cash flows of general funds (and restricted funds of
governmental entities)?

2. For investor-owned providers, are the basic financial statements similar to those
of other investor-owned providers?
[AAG, par. 3.24]
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No

N/A

Yes

Cash and Cash Equivalents

II.
A.

General

1. Is restricted cash appropriately segregated from cash available for current
operations?
[ARB 43, Ch. 3A, par. 6 (AC B05.107)]
2. Are restrictions on cash (such as for plant acquisition, debt reduction or working
capital maintenance) appropriately disclosed?
[SFAS 5, pars. 18—19 (AC C59.120)]

B. Personal Fund Accounts
1. Are personal funds of patients, residents and others under an agency
arrangement reported as assets and corresponding liabilities in the balance sheet?

2. Is the amount of personal funds reported as assets disclosed parenthetically on
the balance sheet or in the notes?
[AAG, par. 5.06]
C. Cash Equivalents
1. Is the policy for determining cash equivalents disclosed?
[SFAS 95, par. 10 (AC C25.108)]

III.

--------

--------

---------------

--------

Investments (See Exhibit A)

A. General
1. Are investments of general funds reported as current or noncurrent assets in
conformity with GAAP?
[AAG, par. 6.01]
2. Are the appropriate disclosures made for investments in common stock
accounted for by the equity method?
[APB 18, par. 20 (AC I82.110)]
3. Are other securities (such as real estate) reported at amortized cost, or at lower of
cost or market if an impairment in value is deemed to be other than temporary?
[AAG, par. 6.02c]

--------

--------

--------

B. Debt and Equity Securities (See Exhibit A)1
1. For debt and marketable equity securities classified as available-for-sale or heldto-maturity, are the following disclosures made, by major-security type, for each
balance sheet presented:

a. Aggregate fair value?
b. Gross unrealized holding gains or losses?

---------------

c. Amortized cost basis?

--------

d. Disclosure of major-security types, including:

--------

(1) Equity securities?

(2) Debt securities issued by the U.S. Treasury and other U.S. government
corporations and agencies?
(3) Debt securities issued by states of the U.S. and political subdivisions of
the states?
(4) Debt securities issued by foreign governments?

---------------

(5) Corporate-backed securities?
(6) Mortgage-backed securities?
(7) Other debt securities?

----------------------

(8) Other security types, as deemed appropriate?
[SFAS 115, par. 19 (AC I80.118)]

--------

1 SFAS 115 is not applicable to not-for-profit health care providers.
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--------

No

N/A

Yes

2. For investments in debt securities classified as available-for-sale or held-tomaturity is:

a. Disclosure made about their contractual maturities, as of the date of the latest
balance-sheet date presented (maturity information may be combined in
appropriate groupings)?

_____

b. Disclosure made of the fair value and the amortized cost of debt securities in
at least four maturity groupings:

(1) Within one year?

_____

(2) After one year through five years?

_____

(3) After five years through ten years?

_____

(4) After ten years?
[SFAS 115, par. 20 (AC I80.119)]

_____

3. Is consideration given to separate disclosure for securities not due at a single date
and the basis for allocation if such securities are allocated?
[SFAS 115, par. 20 (AC I80.119)]
4. Are realized gains or losses on the sale of investments of endowment funds
added to or deducted from the funds' principal (unless such amounts are legally
available for other use or chargeable to other funds)?
[AAG, par. 6.13]

_____

5. Are income and net realized gains or losses on investments of restricted funds
(other than endowment funds) added to or deducted from the respective fund
balance (unless such amounts are legally available for other use or chargeable to
other funds)?

_____

a. If such amounts are legally available for unrestricted purposes, are they
reported in the statement of revenues and expenses?

_____

b. Are gains or losses on investment trading between general and restricted
funds and between various categories of restricted funds (such as between
endowment and plant expansion funds) separately disclosed in the financial
statements?
[AAG, par. 6.14]

IV.

_____

_____

Receivables
1. Are charity care revenue and receivables excluded from the financial statements?
[AAG, par. 7.02]

_____

2. Are differences between the estimates originally reported and final settlements:
a. Included in the statement of revenues and expenses (statement of operations)
in the period the settlements are made?

_____

b. Reported in the current period unless they meet the criteria for prior-period
adjustments?
[AAG, par. 7.09; SFAS 16 (AC A35)]

_____

3. Are advances from third-party payors reported as a liability (unless the right of
setoff against a related receivable applies)?
[AAG, par. 7.11]

_____

4. Are deposits received from individuals reported as a liability (to the extent that a
right of setoff does not exist)?
[AAG, par. 7.12]
5. Are receivables (less an allowance for uncollectibles, discounts, and contractual
adjustments) reported as current assets in the general funds?

_____

a. If the terms of payment are extended beyond one year from the balance-sheet
date, is that portion classified as noncurrent?

_____

b. Is consideration given to segregating amounts due from third-party payors for
retroactive adjustments of items (such as final settlements or appeals)?
[AAG, par. 7.16]
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_____

_____

Yes

6. If financial statements present assets and liabilities by fund groups:
a. Are interfund receivables or payables reported separately by fund?

b. In a classified balance sheet, are they reported as current or noncurrent in
general funds?

7. If financial statements do not present assets and liabilities by fund groups, are
interfund receivables and payables eliminated?
8. Are circumstances and terms of formal interfund borrowing agreements
disclosed?
[AAG, par. 7.17]
9. Are pledges reported in the period in which they were made?

a. Are pledges reported net of an allowance for uncollectible amounts?
b. Are unrestricted pledges reported in the statement of revenues and expenses
(statement of operation)?

c. If a portion of a pledge is to be applied during some future period, is that part
reported in the general fund in the period in which it is received as deferred
revenue or, if restricted, as an addition to donor-restricted funds?
d. If pledges are restricted in any other way, are they reported as additions to
donor-restricted funds?
[AAG, par. 7.18]

10. Are all receivables reported net of any related allowance for uncollectible
amounts, with appropriate disclosure?
[AAG, par. 7.19; APB 12, par. 3 (AC V18.102)]

11. Are accounts and notes receivable from officers, employees, and affiliated
organizations shown separately with appropriate disclosures?
[ARB 43, Ch. 1A, par. 5 (AC R36.105)]

V.

Property and Equipment, Supplies, and Other Assets
1. Is property and equipment of donor-restricted funds (such as property received as
a donation to endowment funds) reported in the appropriate donor-restricted
fund?
[AAG, par. 8.07]

2. Are donor or legal restrictions on the proceeds from the disposition of property
and equipment disclosed?
[AAG, par. 8.06]
3. For depreciable assets, do the financial statements or notes disclose:
a. Depreciation expense for each period?
b. Balances of major classes of depreciable assets by nature or function?

c. Accumulated depreciation, either by major classes of assets or in total?
d. The method or methods used in computing depreciation with respect to major
classes of depreciable assets?
[APB 12, par. 5 (AC D40.105)]
4. Do disclosures include the method and period of amortization of intangible
assets?
[APB 22, par. 13 (AC A10.106)]

5. In a classified balance sheet:
a. Are deferred tax assets classified as current or noncurrent based on the
classification of the related asset or liability for financial reporting?
[SFAS 109, par. 41 (AC I27.140)]
b. Are deferred tax assets not related to an asset or liability for financial
reporting (including those related to carryforwards) classified according to the
expected reversal date of the temporary difference?
[SFAS 109, pars. 41 and 288p (AC I27.140)]
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No

N/A

Yes

c. Is the valuation allowance for a particular tax jurisdiction allocated between
current and noncurrent deferred tax assets for that tax jurisdiction on a pro
rata basis?

[SFAS 109, par. 41 (AC I27.140)]

d. Are the following items offset and presented as a single amount for a
particular taxpaying component and within a particular taxpaying
jurisdiction:
(1) All current deferred tax liabilities and assets?

(2) All noncurrent deferred tax liabilities and assets?
[SFAS 109, par. 42 (AC I27.141)]
6. Are the totals of (a) all deferred tax assets and (b) the related valuation allowance
recognized in the balance sheet disclosed?
[SFAS 109, par. 43 (AC 127.142)]
7. Is an asset (prepaid pension cost) recognized if net periodic pension cost is less
than amounts the employer has contributed to the plan?
[SFAS 87, par. 35 (P16.129)]
8. If an additional minimum pension liability is recognized, is an equal amount
recognized as an intangible asset, provided that the asset recognized does not
exceed the amount of unrecognized prior-service cost?
[SFAS 87, pars. 36—37 (AC P16.130—.131)]

Current Liabilities, Notes Payable, and Other Debt

VI.
A.

Current Liabilities

1. Do current liabilities include:

a. Obligations for items that enter the operating cycle?
b. Collections received in advance of the performance of services?

c. Debts that arise from operations directly related to the operating cycle?

d. Other liabilities whose regular and ordinary liquidation is likely to occur
within a relatively short time period?
e. Obligations that, by their terms, are due on demand or will be due within one
year (or operating cycle, if longer) from the balance-sheet date, even though
liquidation may not be expected within that period?
[ARB 43, Ch. 3A, pars. 7—8 (AC B05.108—.109); SFAS 78, par. 5 (AC
B05.109A)]
2. Do current liabilities exclude short-term obligations that the provider intends to
refinance on a long-term basis, provided the provider has demonstrated the
ability to consummate the long-term financing?
[SFAS 6, pars. 8—14 (AC B05.112—.116)]

B. Notes Payable and Other Debt
1. Is there adequate disclosure of interest rates, maturities, and other terms and
conditions provided in loan agreements and bond indentures (such as assets
pledged as collateral, and covenants to reduce debt, and maintain working
capital)?
[FASCON 5, par. 11; SFAS 5, par. 18 (AC C59.120)]
2. Are the combined aggregate amounts of maturities and sinking fund
requirements for all long-term borrowings disclosed for each of the five years
following the date of the latest balance sheet presented?
[SFAS 47, par. 10b (AC C32.105b)]

3. If note is noninterest bearing or has an inappropriate stated interest rate:
a. Is the discount or premium presented as a deduction from or addition to the
face amount of the note?
12

No

N/A

Yes

b. Does the disclosure include the effective interest rate and face amount of the
note?

--------

c. Is amortization of the discount or premium reported as interest expense?

--------

d. Are issue costs reported in the balance sheet as deferred charges?
[APB 21, par. 16 (AC I69.109)]

--------

4. Are debt conversion features (such as rates and pertinent dates) disclosed?
[FASCON 5, par. 11; APB 14 (AC D10)]

--------

5. If a short-term obligation is to be excluded from current liabilities in a classified
balance sheet, do disclosures include:
a. General description of the financing agreement?
b. Terms of any new obligation incurred or expected to be incurred, or equity
securities issued or expected to be issued as a result of the refinancing?
[SFAS 6, par. 15 (AC B05.118)

---------------

6. For troubled debt restructuring occurring during the current period, do
disclosures include:
a. Description of the principal changes in terms and/or the major features of
settlement?

--------

b. Aggregate gain on restructuring of payables and the related income tax effect?

--------

c. Aggregate net gain or loss on transfers of assets recognized during the period?

--------

d. Per-share amount, if applicable, of the aggregate gain on restructuring of
payables, net of related income tax effect?
[SFAS 15, par. 25 (AC D22.121)]
7. For periods after a troubled debt restructuring, do disclosures include:
a. Extent to which amounts contingently payable are included in the carrying
amount of restructured payables?

b. Total amounts contingently payable, if applicable, and conditions under
which those amounts would become payable or forgiven?
[SFAS 15, par. 26 (AC D22.122)]
8. If there is an early extinguishment of debt, is the difference between reacquisition
price and carrying amount identified as a separate or extraordinary item?
[SFAS 4, par. 8; SFAS 64, par. 4 (AC D14.105)]

--------

---------------

--------

9. If debt is considered to be extinguished early, do disclosures include:
a. A general description of the transaction?
b. The amount of debt that is considered extinguished as long as the debt
remains outstanding?
[SFAS 76, par. 6 (AC D14.108)]
10. Are long-term obligations that are or will be callable by the creditor, either
because the debtor's violation of the debt agreement at the balance-sheet date
makes the obligation callable, or because the violation (if not cured within a
specified grace period) will make the obligation callable, classified as current
unless one of the following conditions is met:
a. The creditor waives or subsequently loses the right to demand repayment for
more than one year (or operating cycle, if longer) from the balance-sheet
date?
b. The obligation contains a grace period within which the debtor may cure the
violation and it is probable that the violation will be cured within that period,
thus preventing the violation from becoming callable?
[SFAS 78, par. 5 (AC B05.109A)]
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---------------

--------

--------

No

N/A

Yes

11. Does the not-for-profit provider report tax-exempt obligations that were issued
for its benefit as liabilities in the general funds?
[AAG, par. 9.04]

_____

12. Is consideration given to the effects, if any, of current and prior tax examinations
on the financial statements and disclosures related to the existence of contingent
liabilities for unrelated business income tax, additional payroll tax liabilities, or
penalties and interest on delinquent taxes?

_____

13. Is disclosure considered for any changes in the provider's activities that could
affect its tax-exempt status?

_____

14. Are disclosures appropriate regarding the provider's tax-exempt status and any
other significant tax matters?

_____

15. Is appropriate disclosure made if unrelated business income tax has not been
accrued on income from:
a. Debt-financed investments that are not functionally related to the exempt
purpose?

_____

b. Certain related entities not engaged in an exempt activity?

_____

c. Pharmacy operations in a medical building for the convenience of physicians'
private patients?

_____

d. A gift shop, cafeteria or food shop that the provider encourages the general
public (except patients, visitors and employees) to use?

_____

e. A parking lot available to the general public (except patients, visitors, and
employees)?

_____

16. Is consideration given to disclosing the effects of the Tax Reform Act of 1986 that
added arbitrage restrictions regarding tax-exempt bonds?
[AAG, pars. 9.19—.33; SFAS 5, pars. 9—10 (AC C59.108—.111)]

VII.
A.

_____

Commitments and Contingencies
Uninsured Medical Malpractice Claims

1. If a minimum amount of a probable loss (usually associated with litigating or
setting malpractice claims) is accrued, is there disclosure as to a reasonable
possibility of an additional potential loss in excess of the amount accrued?

2. If a range of loss cannot be reasonably estimated, is a contingency disclosed?
[AAG, par. 10.04; SFAS 5(AC C59)]
3. Is the program of medical malpractice coverage and basis for loss accruals
disclosed?
[AAG, par. 10.11; SFAS 5(AC C59)]

_____
_____

_____

4. If the provider discounts accrued malpractice claims, are the following disclosed:

B.

a. The carrying amount of the claims?

_____

b. The interest rates or other rates used to discount the claims?
[AAG, par. 10.12]

_____

Retrospectively Rated Premiums

1. If the provider cannot estimate losses from asserted or unasserted malpractice
claims, is the existing contingency disclosed?
[AAG, par. 10.14; SFAS 5(AC C59)]

_____

2. Does the provider disclose that it is insured under a retrospectively rated policy?

_____

3. Does the provider disclose that premiums are accrued based on the ultimate cost
of the experience to date of a group of entities?

_____

4. If losses cannot be estimated, is the existing contingency disclosed?
[AAG, par. 10.15; SFAS 5(AC C59)]
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_____

No

N/A

Yes

C.

Medical Malpractice Claims Insured with Captive Insurance Companies
(Controlled by a parent entity for the main purpose of providing insurance for
the parent)

1. Does the provider disclose that it is insured under a retrospectively rated policy of
a multiprovider captive?

2. Does the provider disclose that premiums are accrued based on the captive's
experience to date?
[AAG, par. 10.18]

3. Is the provider's ownership percentage in the captive disclosed?
4. Is the method of accounting for its investment in and the operations of the
captive disclosed?
[AAG, par. 10.19]
5. If the provider cannot make the necessary estimates of losses from asserted or
unasserted claims, does it disclose the existing contingency?
[AAG, par. 10.19; SFAS 5 (AC C59)]
D.

Trust Funds

1. If trust funds (revocable or irrevocable) are included in the provider's financial
statements:

a. Is a portion of the funds (the amount of assets expected to be liquidated to
pay malpractice claims classified as current liabilities) classified as a current
asset in a classified balance sheet?
b. Is the balance of the funds, if any, classified as a noncurrent asset in a
classified balance sheet?

c. Are trust fund revenue and administrative expenses included in the statement
of revenues and expenses (statement of operations)?
[AAG, par. 10.20]
d. Are estimated losses from asserted and unasserted claims reported?
[AAG, par. 10.21]

e. Is the existence of trust funds and whether they are irrevocable disclosed?
[AAG, par. 10.22]
E.

Prepaid Health Care Services

1. Health Care Costs
a. Is the basis for accruing health care costs disclosed?

b. Are significant business and contractual arrangements with hospitals,
physicians, and other associated entities disclosed?
[SOP 89-5 (AAG, Appendix B), par. 32]

2. Stop-Loss Insurance
a. Are receivables representing amounts recoverable from insurers reported as
assets net of any valuation allowance?

b. Are the nature, amounts, and effects of significant stop-loss insurance
contracts disclosed?
[SOP 89-5 (AAG, Appendix B), par. 49]

F. Other Disclosures
1. Are the nature and, if applicable, amount (or a statement that no loss estimate can
be made) disclosed for loss contingencies (including guarantees)?
[SFAS 5, pars. 9—12 and FASBI 34, pars. 2—3 (AC C59.108—.114)]
2. Are gain contingencies adequately disclosed with care to avoid misleading
implications as to the likelihood of realization?
[SFAS 5, par. 17 (AC C59.118)]
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No

N/A

Yes

3. Are the nature, term, amount and other required information disclosed for long
term unconditional purchase obligations?
[SFAS 47, pars. 7 and 10a (AC C32.102 and .105a)]
4. If an obligation for postemployment benefits (other than pensions) is not accrued
in accordance with SFAS 5 (AC C59) or SFAS 43 (AC C44) only because the
amount cannot reasonably be estimated and the financial statements are for a
fiscal year beginning after December 15, 1993, is the fact of nonaccrual disclosed
in the financial statements?
[SFAS 112, par. 7 (AC P32.105)]

_____

_____

VIII. Net Assets (Equity or Fund Balances)
A.

Financial Statement Presentation

1. Are the equity accounts of investor-owned providers presented in a similar
fashion as other investor-owned businesses?

_____

2. Are the net assets of not-for-profit and governmental providers (that use the
disaggregated method) displayed as general and donor-restricted fund balances?

_____

3. Are the net assets of not-for-profit and governmental providers (that use the
aggregated method) displayed as unrestricted, temporarily restricted or
permanently restricted fund balances as appropriate?
[AAG, par. 11.01]
4. Is the nature of restrictions on donor-restricted resources disclosed?
[AAG, par. 11.02]

_____
_____

5. Shareholders' Equity (Corporations)
a. Do the financial statements include a description, in summary form, sufficient
to explain the pertinent rights and privileges of the various securities
outstanding, (e.g., dividend and liquidation preferences, participation rights,
call prices and dates, conversion or exercise prices or rates and pertinent
dates, sinking fund requirements, unusual voting rights)?
[APB 15, par. 19 (AC E09.110)]

_____

b. For preferred stock, do disclosures include:

(1) Aggregate or per share amounts at which shares may be called or are
subject to redemption?
[APB 10, par. 11 (AC 06.102)]

_____

(2) Aggregate and per share amounts of arrearages in cumulative preferred
dividends?
[APB 15, par. 50, fn. 16 (AC 06.102)]

_____

c. For stock option and stock purchase plans, do disclosures include:
(1) Number of shares under option?

_____

(2) Option price?

_____

(3) Number of shares as to which options are exercisable?

_____

(4) For options exercised, the number of shares involved and option price?
[ARB 43, Ch. 13B, par. 15 (AC C47.123)]

_____

d. Are any appropriations of retained earnings for loss contingencies clearly
identified and included in stockholders' equity?
[SFAS 5, par. 15 (AC R70.103)]
e. Are restrictions on payment of dividends disclosed?
[SFAS 5, pars. 18—19 (AC C59.120)]
f. Are receivables for stock issued or subscribed appropriately identified and
presented as a deduction from capital or, if presented as an asset, stated
separately, clearly labeled, and their status clearly described to distinguish
them from any other type of assets?
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_____
_____

_____

No

N/A

Yes

g. Are the amounts of redemption requirements for all issues of capital stock
that are redeemable at fixed or determinable prices on fixed or determinable
dates disclosed for each of the five years following the date of the latest
balance sheet presented?
[SFAS 47, par. 10 (AC C32.105)]

_____

6. Changes in Net Assets (Fund Balances)
a. When both financial position and results of operations (or revenue and
expenses of general funds) are presented:

(1) Are changes in the separate component accounts of equity (or fund
balances) disclosed?
[APB 12, par. 10 (AC C08.102); AAG, par. 3.24]

(2) Are changes in the number of shares of capital stock disclosed for at least
the latest year and any subsequent interim periods presented (for-profit
only)?
[APB 12, par. 10 (AC C08.102)]

b. Are prior-period adjustments and their resulting effects (both gross and net of
applicable income taxes) appropriately presented and disclosed?
[APB 9, par. 26 (AC A35.107)]

c. If an additional pension liability is required to be recognized and exceeds
unrecognized prior service cost, is the excess (which would represent a net
loss not yet recognized as net periodic pension cost) reported as a separate
component (i.e., a reduction) of equity net of any tax benefits that result from
considering such losses as temporary differences?
[SFAS 87, par. 37 (AC P16.131)]

_____

_____

_____

_____

Revenues, Expenses, Gains, and Losses

IX.
A.

Conceptual Framework for Reporting and Classification

1. Are revenues and expenses (arising from ongoing activities associated with health
care services) classified as operating and displayed as gross amounts?
2. Is display of gains and losses (resulting from peripheral or incidental transactions
and from other events (environmentally related and largely uncontrollable)) as
net amounts considered?
[AAG, pars. 12.01—.02]

_____

_____

3. Are gains and losses classified in relation to major ongoing or central operations
such as:

a. Operating, if related?

_____

b. Nonoperating, if peripheral, incidental or unrelated?
[AAG, par. 12.03]

_____

4. For investments in common stock accounted for by the equity method, is the
investor's share of earnings shown as a single amount except for investee
extraordinary items and prior-period adjustments that are material to the
investor?
[APB 18, pars. 19c—d (AC I
5. Are total research and development costs charged to expenses disclosed for each
period to which a statement of revenues and expenses (operations) is presented?
[SFAS 2, pars. 12—13 (AC R50.108—.109); FASBI 4, par. 5 (AC B50.152); FASBI
6, par. 8 (AC R50.117); SFAS 68, par. 14 (AC R55.112); SFAS 86, par. 3 (AC
Co2.102)]

6. Is the amount of interest cost incurred disclosed in the statements or notes
thereto, and for an accounting period in which some interest cost is capitalized,
the total amount thereof that has been capitalized?
[SFAS 34, par. 21 (AC I67.118)]
7. If the provider accounts for its obligation under a research and development
arrangement as a contract to perform research and development for others, is
there disclosure of:
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_____

_____

_____

No

N/A

Yes

a. The terms of significant agreements under the research and development
arrangement as of the date of each balance sheet presented?
b. The amount of compensation earned or costs incurred under such contracts
for each period for which a statement of revenues and expenses (statement of
operations) is presented?
[SFAS 68, par. 14 (AC R55.112)]

B.

_____

_____

Revenue

1. Is revenue classified based on the type of service (such as patient or resident)
rendered or contracted to be rendered?
[AAG, par. 12.04]

_____

2. Are contributions, tax support, and other subsidies classified as:
a. Gains, when peripheral or incidental to health care activities?

_____

b. Revenues, if deemed ongoing major or central activities to provide health care
services?
[AAG, par. 12.05]

_____

3. Is other revenue (such as from sales and services, other than health care, to
patients, residents, nonpatients or visitors):
a. Classified as operating?
b. Stated separately?
[AAG, pars. 12.06—.07]

4. Are gains and losses properly classified and reported?
[AAG, par. 12.08]
C.

_____
_____
_____

Financial Statement Presentation (See Exhibit A)

1. Is service revenue reported net of contractual charity care and other adjustments?
[AAG, par. 12.11]

2. Do disclosures include the methods of:
a. Revenue recognition?

_____

_____

b. Recording unrestricted and restricted donations and investment income of
both general and restricted funds?

3. With regard to contractual adjustments and third-party settlements, does the
provider identify and explain the estimated amounts payable or receivable?
[AAG, par. 12.13]
4. Are expenses incurred to solicit contributions separately disclosed?
[AAG, par. 12.16]

_____
_____
_____

5. For each period for which an earnings statement is presented, are the following
disclosures made:

a. The proceeds from sales of available-for-sale securities and gross realized
gains and losses on those sales?

_____

b. The basis on which cost was determined in computing realized gain or loss
(i.e., specified identification, average cost, or other method used)?

_____

c. The gross gains and losses included in earnings from transfers of securities
from the available-for-sale category to the trading category?

_____

d. The change in net unrealized holding gain or loss on available-for-sale
securities that is included in the separate component of shareholders' equity
during the period?

_____

e. The change in net unrealized holding gain or loss on trading securities that is
included in earnings during the period?
[SFAS 115, par. 21 (AC I80.120)]

_____

6. For any sales of or transfers from securities classified as held-to-maturity, are the
following disclosed for each period for which an earnings statement is presented:
a. Amortized cost amount of the sold or transferred security?
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_____

No

N/A

Yes

b. Related realized or unrealized gain or loss?
c. The circumstances leading to the decision to sell or transfer the security?
[SFAS 115, par. 22 (AC I80.114—.122)]

7. Income Taxes
a. Are the types of significant temporary differences and carryforwards
disclosed?
[SFAS 109, par. 43 (AC 127.142)]
b. Are the following significant components of income tax expense attributable
to continuing operations for each year presented disclosed in the financial
statements or notes thereto:
(1) Current tax expense or benefit?
(2) Deferred tax expense or benefit (exclusive of the effects of other
components listed below)?

(3) Investment tax credits?
(4) Government grants (to the extent recognized as a reduction of income tax
expense)?
(5) The benefits of operating loss carryforwards?
(6) Tax expense that results from allocating certain benefits, either directly to
contributed capital or to reduce goodwill or other noncurrent intangible
assets of an acquired entity?
(7) Adjustments of a deferred tax liability or asset for enacted changes in tax
laws or rates or a change in the tax status of the provider?
(8) Adjustments of the beginning-of-the-year balance of a valuation
allowance because of a change in circumstances that causes a change in
judgment about the realizability of the related deferred tax asset in future
years?
[SFAS 109, par. 45 (AC I27.144)]
c. Is the amount of income tax expense or benefit allocated to continuing
operations and the amounts separately allocated to other items disclosed for
each year for which those items are presented?
[SFAS 109, pars. 35—39 and 46 (AC I27.134—.138 and .145)]
d. Is the nature of significant reconciling items disclosed?
[SFAS 109, par. 47 (AC I27.146)]

e. Are the amounts and expiration dates of operating loss and tax credit
carryforwards for tax purposes disclosed?
[SFAS 109, par. 48 (AC I27.147)]
f. If the provider is a member of a group that files a consolidated tax return, are
the following items disclosed in its separately-issued financial statements:

(1) The aggregate amount of current and deferred tax expense for each period
presented, and the amount of any tax-related balances due to or from
affiliates as of the date of each balance sheet presented?
(2) The method by which the consolidated amount of current and deferred
tax expense is allocated to members of the group and the nature and
effect of any changes in that method (and in determining related balances
to or from affiliates) for each period presented?
[SFAS 109, par. 49 (AC I27.148)]
8. Discontinued Operations
a. Are operations of a segment that are discontinued or are the subject of a
formal plan for disposition:

(1) Reported separately from continuing operations and as a component
(including applicable income taxes) of operations before extraordinary
items?
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No

N/A

Yes

(2) Accompanied by disclosure in the notes of revenue applicable to the
discontinued operations?
b. Is gain or loss from disposal of a discontinued segment reported separately
(including applicable income taxes) in conjunction with results of
discontinued operations as a component of income before extraordinary
items?
[APB 30, pars. 8, 13 and 15—18 (AC I13.101—.103, .105—.106 and .108—
.109)]
c. For the period encompassing the measurement date, do notes to financial
statement disclose:
(1) Identity of the segment discontinued?

(2) Expected disposal date, if known?
(3) Expected manner of disposal?
(4) Description of the remaining assets and liabilities of the discontinued
segment at the balance-sheet date?
(5) Results of operations and any proceeds from disposal of the discontinued
segment during the period from the measurement date to the balancesheet date?
[APB 30, par. 18 (AC I13.108—.109)]
d. For periods after the measurement date and including the disposal, do notes
to financial statements disclose the information required for the period
encompassing the measurement date and the actual date and results of
disposal compared with the prior estimates?
[APB 30, par. 18 (AC I13.108—.109)]
9. Extraordinary Items
a. Are extraordinary items segregated and shown (including applicable income
taxes) after income before extraordinary items and before net income?
[APB 30, par. 10—12 (AC I17.102—.103)]
b. Are descriptive captions and amounts (including applicable income taxes)
presented for individual extraordinary events or transactions, preferably on
the face of the income statement, if practicable?

c. Do disclosures include descriptions of extraordinary events or transactions
and the principal items entering into determination of extraordinary gains or
losses?
[APB 30, par. 11 (AC I17.102)]
d. For gains or losses from extinguishment of debt classified as extraordinary
items, do disclosures include:

(1) Description of the extinguishment transactions, including the sources of
any funds used to extinguish the debt if it is practicable to identify the
sources?

(2) Income tax effect in the period of extinguishment?
(3) Per share amount (if applicable) of the aggregate gain or loss net of
related income tax effect?
[SFAS 4, pars. 8—10 (AC I17.104 and D14.105—.107)]
e. For an adjustment of an extraordinary item reported in a prior period (except
for correction of an error):
(1) Is the adjustment classified separately as an extraordinary item in the
current period?
(2) Are the nature, origin, and amount of the item disclosed?
[SFAS 16, par. 16(c) (AC I17.119)]
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No

N/A

Yes

10. Are material events or transactions that are either unusual in nature or of
infrequent occurrence, but not both (and therefore not meeting criteria for
extraordinary items):

a. Reported as a separate component of income from continuing operations?

--------

b. Accompanied by disclosure of the nature and financial effects of each event?
[APB 30, par. 26 (AC I22.101)]

--------

11. Do disclosures for advertising costs include:

a. The accounting policy selected from the two alternatives in the beginning of
paragraph 26 of SOP 93-7 for reporting advertising, indicating whether such
costs are expensed as incurred or the first time the advertising takes place?
b. A description of the direct-response advertising reported as assets (if any), the
accounting policy for it, and the amortization period?
c. The total amount charged to advertising expense for each income statement
presented, with separate disclosure of amounts, if any, representing a write
down to net realizable value?
d. The total amount of advertising reported as assets in each balance sheet
presented?
[SOP 93-7, par. 49]

X.

_____
_____

_____
_____

Statement of Cash Flows
A.

Is a statement of cash flows presented as a basic financial statement for each
period for which a statement of revenues and expenses (statement of operations)
is presented for:

1. General funds of a nonprofit or governmental entity?

_____

2. Restricted funds of a governmental entity?

_____

3. Any investor-owned entity?
[SFAS 95, par. 3 (AC C25.101); AAG, pars. 3.24—.25]

_____

B.

Does the statement of cash flows explain the effect of cash flows by showing the
change in cash and cash equivalents?
[SFAS 95, par. 7 (AC C25.105)]

C.

Is the policy for defining cash equivalents disclosed?
[SFAS 95, par. 10 (AC C25.108)]

D.

If the direct method is used, is a reconciliation of the excess of revenues and
expenses (income) to net cash flow from operating activities provided in a
separate schedule?
[SFAS 95, par. 30 (AC C25.128)]

E.

_____

_____

If the indirect method is used:

1. Is the same amount for net cash flow from operating activities reported indirectly
by adjusting the excess of revenues and expenses (income) to reconcile it to net
cash flow from operating activities?
[SFAS 95, par. 28 (AC C25.126)]
2. Is the reconciliation of the excess of revenues and expenses (income) to net cash
flow from operating activities reported, either within the statement of cash flows
or provided in a separate schedule, with the statement of cash flows reporting
only the net cash flow from operating activities?
[SFAS 95, par. 30 (AC C25.128)]

F.

_____

_____

_____

Are cash receipts and cash payments for the following transactions classified as
cash flows from operating activities:

1. Interest received on loans?

_____

2. Insurance proceeds except those directly related to investing or financing
activities?

_____
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No

N/A

Yes

3. Interest paid to creditors?

4. Payments to suppliers and employees?

5. Payments to governments for taxes, duties, fines, and other fees or penalties?
6. Payments to settle lawsuits?

7. Contributions to charities?
[SFAS 95, pars. 22—23 (AC C25.120—.121)]
G.

Are cash receipts and cash payments for the following transactions classified as
cash flows from investing activities:

1. Receipts from collections or sales of loans?

2. Receipts from sales of property?
3. Loans to others?
4. Payments to acquire property?
[SFAS 95, pars. 16—17 (AC C25.114—.115)]
H.

Are cash receipts and cash payments for the following transactions classified as
cash flows from financing activities:

1. Proceeds from issuing debt?

2. Repayments for amounts borrowed?
[SFAS 95, pars. 19—20 (AC C25.117—.118)]
I.

Except for certain items whose turnover is quick, amounts are large and maturities
are short, are cash receipts and cash payments from investing and financing
activities shown separately on the statement of cash flows?
[SFAS 95, pars. 12—13 and 31 (AC C25.110—.111 and .129)]

J.

Are noncash investing and financing activities (such as converting debt to equity)
summarized in a separate schedule or the notes?
[SFAS 95, par. 32 (AC C25.134)]

XI. Related Organizations and Economic Dependency
A. Consolidation and Combination (See Exhibit A)
1. If the provider and another entity are related and they meet the criteria for
consolidation or combination ("consolidation"), are consolidated or combined
("consolidate") financial statements presented?
[AAG, par. 13.2; ARB 51 (AC C51); SFAS 94 (AC C51)]
2. If consolidated statements are presented:

a. Is the consolidation policy disclosed?
[ARB 51, par. 5 (AC C51.108); APB 22, par. 13 (AC A10.106)]
b. When the financial reporting periods of consolidated entities differ, is
recognition given, by disclosure or otherwise, to the effect of intervening
events that materially affect financial position or results of operations?
[ARB 51, par. 4 (AC C51.107); FASBI13, pars. 6—8 (AC I89.120—.122)]
3. Do disclosures about formerly unconsolidated subsidiaries that are now
consolidated include summarized information about the assets, liabilities, and
results of operations (or separate statements) in the consolidated financial
statements or notes?
[AAG, par. 13.02; SFAS 94, par. 14 (AC C51.120A)]
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No

N/A

Yes

B. Related Parties and Economic Dependency
1. If the entity does not meet the criteria for consolidation or combination, but
controls and is the sole beneficiary of a related organization's activities, is
summarized financial data of the related organization disclosed?
[AAG, pars. 13.03—.04]
2. For any related party that is not consolidated or combined, does the entity
disclose (even if there are no transactions between them):
a. The nature of the relationship between the entity and the related party?
b. If there are material transactions between the entity and the related party:
(1) A description of the transactions, including transactions to which nominal
or no amounts were ascribed?
(2) The amount of such transactions?
(3) Amounts due from or to the related party and, if not apparent, the terms
and manner of settlement?
AAG, par. 13.05; SFAS 13, par. 29 (AC L10.125); SFAS 57, pars. 2—4
(AC R36.102—.104)]

XII.

---------------

Continuing Care Retirement Communities (CCRCs)

A. Refundable Advance Fees
1. Is the estimated amount of advance fees expected to be refunded to current
residents reported as a liability?
2. Is the remaining amount of advance fees reported in the balance sheet as deferred
revenue?
3. Are the following disclosed:
a. The gross amount of contractual refund obligations under existing contracts?
b. The CCRC's refund policy?
4. Are amounts refunded disclosed in the statement of cash flows as a financing
transaction?
[SOP 90-8 (AAG, Appendix C), par. 22]
5. Is the method of accounting, including the amortization method, for deferred
revenue disclosed?
[AAG, par. 9.34; SOP 90-8 (AAG, Appendix C), pars. 23, 31 and 43]
B. Fees Refundable to Residents Only From Reoccupancy Proceeds of a Contract
Holder's Unit
1. Are the following reported as deferred revenue:
a. The portion of fees to be paid to current residents or their designees, only to
the extent of a contract holder's unit reoccupancy proceeds, if law and
management policy and practice support the withholding of refunds under
this condition?
b. Similar amounts received from new residents in excess of the amount to be
aid to previous residents or their designees?
SOP 90-8 (AAG, Appendix C), par. 31]
C. Nonrefundable Advance Fees
1. Are nonrefundable advance fees reported as deferred revenue?
2. Is unamortized deferred revenue reported as revenue upon a resident's death or
contract termination?
[SOP 90-8 (AAG, Appendix C), pars. 23 and 43]

p

D. Obligation to Provide Future Services and Use of Facilities to Current
Residents
1. If the obligation to provide future services and use of facilities to current residents
under continuing-care contracts results in a liability, are the following disclosed:
a. The carrying amount of the liability?
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------------------------------------

--------

No

N/A

Yes

b. The interest rate used to discount that liability?
[SOP 90-8 (AAG, Appendix C), par. 55]

E.Costs of Acquiring Initial Continuing-Care Contracts
1. Are costs of acquiring initial continuing-care contracts capitalized if they are
expected to be recovered from future contract revenues?

2. Are continuing-care contract acquisition costs expensed if incurred after (a) the
CCRC is substantially occupied or (b) one year following completion?
[SOP 90-8 (AAG, Appendix C), par. 63]

XIII. Financial Statements and Notes—General
A.

Titles and References

1. Are the financial statements suitably titled?
[SAS 62, par. 7 (AU 623.07)]

2. Does each statement include a general reference that the notes are an integral
part of the financial statement presentation?

3. Do the note captions and the referencing from the applicable statement
classifications seem appropriate?
[FASCON, par. 18]
B.

Disclosure of Accounting Policies

1. Is a description of all pertinent accounting policies of the provider presented as an
integral part of the financial statements?
[APB 22, pars. 8—9 (AC A10.102—.103)]

2. Does disclosure of significant accounting policies encompass important
judgments as to the appropriateness of principles concerning recognition of
revenue and allocation of asset costs to current and future periods?
[APB 22, par. 12 (AC A10.105)]
3. Does disclosure of significant accounting policies include appropriate reference to
details presented elsewhere (in the statements and notes thereto) so duplication
of details is avoided?
[APB 22, par. 14 (AC A10.107)]
C. Accounting Changes
1. For an accounting change, does disclosure in the period of the change include:
a. Nature of the change?

b. Justification for the change, including a clear explanation of why the newly
adopted principle is preferable?

c. Effect on income?
[APB 20, par. 17 (AC A06.113)]
2. For changes in accounting principle (excluding specific exceptions related to an
initial public offering, change in the reporting entity, or adoption of certain
authoritative pronouncements):
a. If comparative financial statements are included, are they presented as
previously reported?

b. Is the cumulative effect of the change (direct effects and income tax effects
only) on beginning retained earnings for the period of the change shown in
the statement of revenues and expenses (statement of operations) of that
period, after any extraordinary items and before net revenue and gains in
excess of expenses and losses (net income)?

c. Is the effect of adopting the new accounting principle on revenue and gains in
excess of expenses and losses (income) before extraordinary items and net
revenue and gains in excess of expenses and losses (net income) (and
applicable per share data) disclosed for the period of the change?
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No

N/A

Yes

d. Are pro forma revenues and gains in excess of expenses and loss (income)
before extraordinary items and net revenue and gains in excess of expenses
and losses (net income) shown on the face of the statement of revenue and
expenses (statement of operations) for all periods presented as if the newly
adopted accounting principle had been applied during all periods affected?

e. If pro forma amounts or cumulative effects cannot be determined, are the
reasons disclosed?
[APB 20, pars. 12, 17—22, 24—26, 29 and 34 (AC A06.113—.118, .120—.122
and .125, and A35.112 and .114); FASBI 20, par. 5 (A06.127)]

3. Is the correction of an error shown as a prior-period adjustment with disclosure of
the following in the period of its discovery and correction:
a. Nature of the error in previously issued financial statements?
b. Effect of its correction on revenue and gains in excess of expenses and losses
(income) before extraordinary items and net revenue and gains in excess of
expenses and losses (net income) (and related per share amounts if
applicable)?
[APB 20, par. 36 (AC A35.105); SFAS 109, par. 288n (AC A35.103)]

---------------

--------

--------

D. Financial Instruments
1. Except for certain excluded items (SFAS 105, pars. 14—15 (AC F25.104—.105)),
are the following disclosed in the financial statements or notes for each class of
financial instruments with off-balance-sheet risk:
a. The face or contract amount, or notional principal amount if there is no face
or contract amount?

--------

b. The nature and terms, including, at a minimum, a discussion of:

(1) Credit and market risk of those instruments?
(2) Cash requirements of those instruments?
(3) Related accounting policy, as required by APB 22, Disclosure of
Accounting Policies (AC A10)?
[SFAS 105, par. 17 (CT F25.112)]
2. For financial instruments with off-balance-sheet credit risk (except for the items
excluded in SFAS 105 (AC F25)), are the following disclosed, either in the
financial statements or in the notes, by class of financial instrument:
a. The amount of accounting loss the entity would incur if any party to the
financial instrument failed completely to perform according to the terms of
the contract and if the collateral or other security, if any, for the amount due
proved to be of no value to the entity?

--------------_____

_____

b. Regarding collateral or other security to support financial instruments subject
to credit risk:

(1) The entity's policy of requiring such collateral or other security?

_____

(2) Information about the entity's access to that collateral or other security?

_____

(3) The nature and a brief description of the collateral or other security
supporting those financial instruments?
[SFAS 105, par. 18 (AC F25.113)]
3. Do disclosures of all significant concentrations of credit risk arising from all
financial instruments, whether from an individual counterparty or groups of
counterparties (except for certain insurance and investment contracts, purchase
and pension obligations and substantively extinguished debt), include:
a. Information about the (shared) activity, region, or economic characteristic that
identifies the concentration?
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--------

--------

No

N/A

Yes

b. The amount of the accounting loss due to credit risk the entity would incur if
any party to the financial instruments that make up the concentration failed
completely to perform according to the terms of the contracts and if the
collateral or other security, if any, for the amount due proved to be of no
value to the entity?

_____

c. Regarding collateral or other security to support financial instruments subject
to credit risk:
(1) The entity's policy of requiring such collateral or other security?

_____

(2) Information about the entity's access to that collateral or other security?

_____

(3) The nature and a brief description of the collateral or other security
supporting those financial instruments?
[SFAS 105, pars. 14 and 20 (AC F25.104 and .115)]

_____

4. Is the fair value of financial instruments for which it is practicable to estimate that
value (except for certain excluded items and trade receivables and payables
whose amount approximates fair value) disclosed in the financial statements or
accompanying notes?
5. Are the methods and significant assumptions used to estimate the fair value of
financial instruments disclosed?
[SFAS 107, par. 10 (AC F25.115C)]

6. If it is not practicable to estimate the fair value of a financial instrument, are the
following disclosed:
a. Information pertinent to estimating the fair value of that financial instrument
or class of financial instruments, such as the carrying amount, effective
interest rate, and maturity?
b. The reasons why it is not practicable to estimate fair value?
[SFAS 107, par. 14 (AC F25.115G)]
E.

_____
_____

_____
_____

Nonmonetary Transactions

1. Do disclosures include:

F.

a. Nature of the transactions?
b. Basis of accounting for the assets transferred?

_____
_____

c. Gains or losses recognized on the transfers?
[APB 29, par. 28 (AC 01.102 and N35.120)]

_____

Subsequent Events

1. Are the financial statements adjusted for any changes in estimates resulting from
subsequent events that provide additional evidence about conditions that existed
at the balance-sheet date?
[SFAS 5, par. 8 (AC C59.105); SAS 1, secs. 560.03—.04, .07 and 561.01—.09 (AU
560.03—.04, .07 and 561.01—.09)]

_____

2. Are subsequent events that provide evidence about conditions that did not exist
at the date of the balance sheet, but arose subsequent to that date, adequately
disclosed to keep the financial statements from being misleading?
[SFAS 5, par. 11 (AC C59.112); APB 16 (AC B50.120); SAS 1, secs. 560.05—. 07,
.09 and 561.01—.09 (AU 560.05—. 07, .09 and 561.01—.09)]

_____

G. Pension Plans
1. If there is a defined benefit plan, do disclosures include:
a. A description of the plan, including employee groups covered, type of benefit
formula, funding policy, types of assets held and significant nonbenefit
liabilities, if any, and the nature and effect of significant matters affecting
comparability of information for all periods presented?

_____

b. The amount of net periodic pension cost for the period showing separately
the service cost component, the interest cost component, the actual return on
assets for the period, and the net total of other components?

_____
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No

N/A

Yes

c. A schedule reconciling the funded status of the plan with amounts reported in
the employer's balance sheet, showing separately:
(1) The fair value of plan assets?
(2) The projected benefit obligation identifying the accumulated benefit
obligation and the vested benefit obligation?
(3) The amount of unrecognized prior-service cost?
(4) The amount of unrecognized net gain or loss (including asset gains and
losses not yet reflected in market-related value)?
(5) The amount of any remaining unrecognized net obligation or net asset
existing at the date of initial application of SFAS 87 (AC P16)?
(6) The amount of any additional liability recognized pursuant to SFAS 87,
paragraph 36 (AC P16.130)?
(7) The amount of net pension asset or liability recognized in the balance
sheet pursuant to SFAS 87, paragraphs 35—36 (AC P16.129—.130)
(which is the net result of combining the preceding six items)?

d. The weighted-average assumed discount rate and rate of compensation
increase (if applicable) used to measure the projected benefit obligation and
the weighted-average expected long-term rate of return on plan assets?

e. If applicable, the amount and types of securities of the employer and related
parties included in plan assets and the approximate amount of annual
benefits of employees and retirees covered by annuity contracts issued by the
employer and related parties (also, if applicable, the alternative amortization
methods used pursuant to SFAS 87, paragraphs 26 and 33 (AC P16.120 and
.127), and the existence and nature of the commitment discussed in paragraph
41 (AC P16.135))?
[SFAS 87, par. 54 (AC P16.150)]
f. If more than one defined benefit plan exists:
(1) Are the disclosures required by Step H.1. above aggregated for all of the
employee's single-employer defined benefit plans or disaggregated in
groups so as to provide the most useful information?
(2) Are plans with assets in excess of accumulated benefit obligations not
aggregated with plans that have accumulated benefit obligations that
exceed plan assets?
[SFAS 87, par. 56 (AC P16.153)]

2.

If there are one or more defined contribution plans, do disclosures include:
a. A description of the plans, including employee groups covered, the basis for
determining contributions, and the nature and effect of significant matters
affecting comparability of information for all periods presented?

b. The amount of cost recognized during the period?
[SFAS 87, par. 65 (AC P16.162)]

3. If the substance of a plan having characteristics of both defined benefits and
contributions is to provide a defined benefit, are disclosures in accordance with
the requirements applicable to a defined benefit plan as described in Step H.1.
above?
[SFAS 87, par. 66 (AC P16.163)]
4. If there are one or more multiemployer plans, do disclosures include:
a. A description of the multiemployer plans, including the employee groups
covered, the type of benefits provided (defined benefit or defined
contribution), and the nature and effect of significant matters affecting
comparability of information for all periods presented?

b. The amount of cost recognized during the period?
[SFAS 87, par. 69 (AC P16.166)]
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No

N/A

Yes

5. If there is a settlement and/or curtailment of a defined benefit pension plan and/
or termination of benefits under such plan, do disclosures include:
a. A description of the nature of the event(s)?
b. The amount of gain or loss recognized?
[SFAS 88, par. 17 (AC P16.187)]

H. Postretirement Benefits Other Than Pensions
1. If there are one or more defined benefit postretirement plans, do disclosures
include:

a. A description of the substantive plans that is the basis for the accounting,
including the nature of the plans, any modifications of the existing cost
sharing provisions that are encompassed by the substantive plans, and the
existence and nature of any commitment to increase monetary benefits
provided by the plans, employee groups covered, types of benefits provided,
funding policy, types of assets held and significant nonbenefit liabilities, and
the nature and effect of significant matters affecting the comparability of
information for all periods presented, such as the effect of a business
combination or divestiture?
b. The amount of net periodic postretirement benefit cost showing separately
the service cost component, the interest cost component, the actual return on
plan assets for the period, amortization of the unrecognized transition
obligation or transition asset, and the net total of other components?

c. A schedule reconciling the funded status of the plans with amounts reported
in the employer's balance sheet, showing separately:
(1) The fair value of plan assets?

(2) The accumulated postretirement benefit obligation, identifying separately
the portion attributable to retirees, other fully eligible plan participants,
and other active plan participants?
(3) The amount of unrecognized prior-service cost?
(4) The amount of unrecognized net gain or loss (including plan asset gains
and losses not yet reflected in market-related value)?
(5) The amount of any remaining unrecognized transition obligation or
transition asset?
(6) The amount of net postretirement benefit asset or liability recognized in
the balance sheet, which is the net result of combining the preceding five
items?
d. The assumed health care cost trend rate(s) used to measure the expected cost
of benefits covered by the plan (gross eligible changes) for the next year and a
general description of the direction and pattern of change in the assumed
trend rate(s) thereafter, together with the ultimate trend rate(s) and when the
rate(s) is expected to be achieved?
e. The weighted average of the assumed discount rate(s) and rate(s) of
compensation increase (for pay-related plans) used to measure the
accumulated postretirement benefit obligation and the weighted average of
the expected long-term rate(s) of return on plan assets and, for plans whose
income is segregated from the employer's investment income for tax
purposes, the estimated income tax rate(s) included in that rate of return?
f. The effect of a one-percentage-point increase in the assumed health care cost
trend rates for each future year on:

(1) The aggregate of the service and interest cost components of net periodic
postretirement health care benefit cost?

(2) The accumulated postretirement benefit obligation for health care benefits
(for purposes of this disclosure, all other assumptions shall be held
constant and the effects shall be measured based on the substantive plan
that is the basis for the accounting)?
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No

N/A

Yes

g. The amounts and types of securities of the employer and related parties
included in plan assets, and the approximate amount of future annual benefits
of plan participants covered by insurance contracts issued by the employer
and related parties?
h. Any alternative amortization method used?
i. The amount of gain or loss recognized during the period for a settlement or
curtailment and a description of the nature of the event(s)?

j. The cost of providing special or contractual termination benefits recognized
during the period and a description of the nature of the event(s)?
[SFAS 106, par. 74 (AC P40.169)]
2. If more than one defined benefit postretirement plan exists:
a. Are the disclosures aggregated for all of an employer's single-employer
defined benefit postretirement plans or disaggregated in groups so as to
provide the most useful information (except that the aggregate plan assets
and the aggregate accumulated postretirement benefit obligation of the
underfunded plans should be separately disclosed)?
[SFAS 106, par. 77 (AC P40.172)]
b. Are plans that primarily provide postretirement health care benefits and plans
that primarily provide other postretirement welfare benefits separately
disclosed if the accumulated postretirement benefit obligation of the latter
plans is significant relative to the aggregate accumulated postretirement
benefit obligation for all of the plans?
[SFAS 106, par. 78 (AC P40.173)]

3. If there is a multiemployer plan, do disclosures include:
a. A description of the multiemployer plan(s), including the employee groups
covered, the type of benefits provided (defined benefit or defined
contribution), and the nature and effect of significant matters affecting
comparability of information for all periods presented?
b. The amount of postretirement benefit cost recognized during the period, if
available (otherwise, the amount of the aggregate required contribution for
the period to the general health and welfare benefit plan that provides health
and welfare benefits to both active employees and retirees)?
[SFAS 106, par. 82 (AC P40.178)]

4. If there are one or more defined contribution postretirement plans, are the
following items disclosed separately from defined benefit postretirement plan
information:
a. A description of the plan(s), including employee groups covered, the basis for
determining contributions, and the nature and effect of significant matters
affecting comparability of information for all periods presented?

b. The amount of cost recognized during the period?
[SFAS 106, par. 106 (AC P40.198)]
I.

Lessors

1. Are lessor disclosures appropriate and adequate?
[SFAS 13, pars. 23, 29 and 47; SFAS 91, par. 25d (AC L10.119 .125 and .149)]

J.

Lessees

1. For capital leases do disclosures include:

a. Gross amounts of assets recorded by major classes, as of the date of each
balance sheet presented?
b. Future minimum lease payments, as of the date of the latest balance sheet
presented, in total and for each of the next five years, with separate
deductions for executory costs and imputed interest to reduce net minimum
lease payments to present value?
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No

N/A

Yes

c. Total future minimum sublease rentals under noncancelable subleases as of
the date of the latest balance sheet presented?
d. Total contingent rentals actually incurred for each period presented?

e. Assets recorded under capital leases and the related accumulated
amortization, and obligations under those leases identified separately in the
balance sheet or a note?
[SFAS 13, pars. 13 and 16 (AC L10.112a)]
2. For operating leases that have initial or remaining noncancelable lease terms in
excess of one year, do disclosures include:
a. Future minimum rental payments required as of the latest balance sheet
presented in total and for each of the next five years?
b. Total future minimum rentals under noncancelable subleases as of the date of
the latest balance sheet presented?
[SFAS 13, par. 16b (AC L10.112b)]
3. For all operating leases do disclosures include rental expense for each period
presented, with separate amounts for minimum rentals, contingent rentals, and
sublease rentals?
[SFAS 13, par. 16c (AC L10.112c)]

4. Do disclosures include a general description of the lessee's leasing arrangements
including, but not limited to:
a. Bases for determination of contingent rentals?

b. Terms of any renewal or purchase options or escalation clauses?

c. Restrictive covenants?
[SFAS 13, par. 16d (AC L10.112d)]

K. Other Liabilities and Deferred Credits
1. If the entity is subject to income taxes:

a. Are deferred tax liabilities classified as current or noncurrent based on the
related asset or liability for financial reporting?
[SFAS 109, par. 41 (AC I27.140)]
b. Are deferred tax liabilities not related to an asset or liability for financial
reporting classified according to the expected reversal date of the temporary
difference pursuant to SFAS 37?
[SFAS 109, par. 41 (AC I27.140)]
c. Are the following items offset and presented as a single amount for a
particular tax-paying component and within a particular tax-paying
jurisdiction:

(1) All current deferred tax liabilities and assets?
(2) All noncurrent deferred tax liabilities and assets?
[SFAS 109, par. 42 (AC I27.141)]
d. Are the components of the total of all deferred tax liabilities recognized in the
balance sheet disclosed?
[SFAS 109, par. 43 (AC I27.142)]
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No

N/A

Yes

Exhibit A—Various
The effective date of SFAS 115 is for fiscal years beginning after December 15, 1993.
It is to be initially applied as of the beginning of a fiscal year and cannot be applied
retroactively to prior years' financial statements. An entity may elect to apply this
statement as of the end of an earlier fiscal year for which annual financial statements
have not previously been issued. Until such applications, the following disclosures
remain in effect:
A.

Consolidations and Combination

1. If the parent company includes realized gains or losses of marketable securities in
net income and a consolidated subsidiary does not, is the subsidiary's accounting
treatment for marketable securities conformed with that of the parent?
[SFAS 12, par. 18 (AC I89.112)]
2. If the parent follows specialized accounting practices for marketable securities
and the consolidated subsidiaries do not, are the subsidiaries' current and
noncurrent portfolios consolidated as separate current and noncurrent portfolios
exclusive of the parent and is the information required by SFAS 12, paragraph 12,
disclosed?
[SFAS 12, pars. 12 and 19 (AC I89.106 and .113)]

3. If the consolidated financial statements include more than one accepted practice
of accounting for marketable securities, are the required disclosures for the
various methods disclosed?
[SFAS 12, par. 20 (AC I89.114)]

B.

Marketable Equity Securities

1. For marketable equity securities, do disclosures include:

a. For each balance sheet presented, aggregate cost and market value (each
segregated between current and noncurrent portfolios when a classified
balance sheet is presented) with identification as to which is the carrying
amount?
b. For the latest balance sheet presented, gross unrealized gains and gross
unrealized losses (each segregated between current and noncurrent portfolios
when applicable)?
[SFAS 12, pars. 12b and 16a (AC I89.106b and .110a)]

c. For each period for which a statement of revenues and expenses (statement of
operations) is presented:
(1) Net realized gain or loss included in the statement?
(2) Basis on which cost was determined in calculating realized gain or loss
(such as average cost or FIFO)?
[AAG, par. 6.09; SFAS 12, pars. 12 and 16 (AC I89.106 and .110)]
2. Are significant net realized and net unrealized gains and losses that arose after
the latest balance sheet date, but before issuance of the financial statements,
disclosed?
[AAG, par. 6.10; SAS 1, sec. 560, pars. 5 and 7 (AU 560.05 and .07); SFAS 12,
pars. 13 and 17 (AC 189.107 and .111); FASBI11, pars. 3—4 (AC I89.115—.116);
FASBI13, pars. 5—7 (AC I89.120—.122)]
3. Are losses due to a change in classification of a marketable equity security
between current and noncurrent reported in the statement of revenues and
expenses?
[AAG, par. 6.12; SFAS 12, par. 10 (AC I89.104)]
4. For a portfolio included in current assets in the general funds, are changes in the
valuation allowance disclosed and reported in the statement of revenues and
expenses?
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No

N/A

Yes

5. For a portfolio included in noncurrent assets, or assets in unclassified balance
sheets or restricted funds, are changes in the valuation allowance disclosed and
reported in the respective statement of changes in fund balances or equity?
[AAG, par. 6.12; SFAS 12, par. 11 (AC I89.105)]
C.

Financial Statement Presentation

1. For marketable equity securities, are the following disclosed for each period for
which an income statement is presented:
a. Net realized gain or loss included in determination of net income?
[SFAS 12, par. 12c (AC I89.106c)]

b. For entities with certain specialized accounting practices, the change in net
unrealized gain or loss?
[SFAS 12, par. 16b (AC I89.110b)]

c. Basis on which cost was determined in computing realized gain or loss?
[SFAS 12, par. 12c (AC I89.106c)]
d. The change in valuation allowance(s) during the period and when a classified
balance sheet is presented and the amount of such change included in the
determination of net income?
[SFAS 12, par. 12c (AC I89.106c)]
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No

N/A

FSP Section 21,400

Auditors’Reports Checklist
.01 This checklist has been developed by the staff of the Technical Information Division of the AICPA as a
nonauthoritative practice aid.
.02 Explanation of References:

SAS =

AICPA Statement on Auditing Standards

AU =

Reference to section number in AICPA Professional Standards (vol. 1)

SSARS =

FASB Statements on Standards for Accounting and Review Services

AR =

Reference to section number in AICPA Professional Standards (vol. 2)

.03 Checklist Questionnaire

Yes

No

N/A

a. Addressee?
[SAS 58, par. 9 (AU 508.09)]

--------

--------

--------

b. Date (or dual dates) of the report?
[SAS 1, sec. 530.05 (AU 530.05)]

--------

--------

--------

--------

--------

--------

--------

--------

--------

--------

--------

--------

--------

--------

--------

--------

--------

--------

--------

--------

--------

--------

--------

--------

1. Does the auditor's report include appropriate:

c. A title that includes the word "independent"?
[SAS 58, par.8a (AU 508.08a)]
2. If the auditor is not independent, is a compilation report the highest level of
service performed?
[SAS 26, par. 10 (AU 504.10); SSARS 1, pars. 22 and 38 (AR 100.22 and 38)]

3. Does the reporting language conform with the auditor's standard report on:
a. Financial statements of a single year or period?

b. Comparative financial statements?
[SAS 58, par. 8 (AU 508.08)
4. Does the report include appropriate language for the following situations:
a. Only one basic financial statement is presented and there are no scope
limitations?
[SAS 58, par. 47—48 (AU 508.47—.48)]
b. Audited and unaudited financial statements are presented in comparative
form?
[SAS 26, pars. 14—17 (AU 504.14—.17)]
5. Is an explanatory paragraph (or other explanatory language) added to the
standard report if:
a. The financial statements are affected by uncertainties concerning future events,
the outcome of which is not susceptible of reasonable estimation at the date
of the auditor's report?
[SAS 58, pars. 16—33 (AU 508.16—.33)]
Note: Consult the Topical Index to the AICPA Professional Standards under
"Uncertainties" for additional references to specific types of uncertainties.
33

Yes

b. There is substantial doubt about the entity's ability to continue as a going
concern for a reasonable period of time and that conclusion is expressed
through the use of the phrase "substantial doubt about its (the entity's) ability
to continue as a going concern"?
[SAS 64, par. 1 (AU 341.12—.13)]

c. There is a material change between periods in accounting principles or in the
method of their application?
[SAS 58, pars. 34—36 (AU 508.34—.36)]
d. In an updated report on comparative financial statements, the current opinion
on the prior period is different from the one previously expressed?
[SAS 58, pars. 77—78 and 81—82 (AU 508.77—.78 and .81—.82)]

e. The prior period financial statements are audited by a predecessor auditor
whose report is not presented?
[SAS 64, par. 2 (AU 508.83)]

f. The auditor's opinion is based in part on the report of another auditor?
[SAS 1, sec. 543 (AU 543); SAS 58, pars.12—13 (AU 508.12—.13)]
g. The financial statements contain a departure from a promulgated accounting
principle when conformity with GAAP would result in a misleading
presentation?
[SAS 58, pars. 14—15 (AU 508.14—.15)]

h. Other information in a document containing audited financial statements is
materially inconsistent with information appearing in the financial
statements?
[SAS 8, par. 4 (AU 550.04)]
i. The auditor decides to emphasize a matter in the report?
[SAS 58, par. 37 (AU 508.37); Interpretation 38 of SAS 1, sec. 410 (AU
9410.17); Interpretation 1 of SAS 57 (AU 9342.03)]
6. Is a qualified opinion or disclaimer of opinion expressed if scope limitations
preclude application of one or more auditing procedures considered necessary in
the circumstances?
[SAS 58, pars. 40—45 (AU 508.40—.45); SAS 31, par. 22 (AU 326.23); SAS 19,
par. 12 (AU 333.12)]

Note: Consult the Topical Index to the AICPA Professional Standards under
"Scope of Audit—Limitations" for additional references to specific types of scope
limitations that could result in either a qualified or disclaimer of opinion.

7. Is a qualified opinion or adverse opinion expressed if a lack of conformity with
GAAP (including inadequate disclosure) is present?
[SAS 58, pars. 49—66 (AU 508.49—.66); SAS 32, par. 3 (AU 431.03)]
Note: Consult the Topical Index to the AICPA Professional Standards under
"Departures from Established Principles," "Adverse Opinions," and "Qualified
Opinions" for additional references to specific types of GAAP departures that
could result in either a qualified or adverse opinion.

8. Is a qualified or adverse opinion expressed if the entity specifically requests the
auditor to report on prior-period financial statements that are incomplete (e.g.,
prior-period totals only)?
[SAS 58, fn. 27 (AU 508, fn. 27)]
9. If a qualified opinion, adverse opinion, or disclaimer of opinion is expressed, are
all the substantive reasons for the opinion or disclaimer disclosed and is the
reporting language appropriately modified?
[SAS 58, pars. 39, 68—69 and 71 (AU 508.39, .68—.69, and .71)]

10. If the auditor is requested to audit Internal Revenue Form 990, "Return of
Organizations Exempt from Income Tax," is the appropriate report prepared?
[Interpretation 2 of SAS 62 (AU 9623.47—.54)]
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No

N/A

N/A

Yes

No

a. State that the audit is performed for the purpose of forming an opinion on the
basic financial statements taken as a whole?

_____

_____

____

b. Specifically identify the accompanying information?

_____

_____

____

c. State that the accompanying information is presented for purposes of
additional analysis and is not a required part of the basic financial statements?

_____

_____

____

_____

_____

____

_____

_____

____

_____

_____

____

11. If information accompanies the basic financial statements and auditor's report in
an auditor-submitted document, does the report on the accompanying
information:

d. State whether the accompanying information is subject to the auditing
procedures applied in the audit of the basic financial statements and the
appropriate expression of opinion or disclaimer?
[SAS 29, pars. 6—11 (AU 551.06—.11)]
12. Is the reporting form and content of SAS 60, paragraphs 9—19, followed when
communicating internal control structure related matters noted in an audit?1
[SAS 60, pars. 9—19 (AU 325.09—.19)]

13. Is the reporting form and content of SAS 72 followed for comfort letters
submitted to underwriters and other requesting parties on tax-exempt bond
offerings?
[SAS 72 (AU 634)]

1 Reportable conditions in internal control structure that have not been corrected must be communicated, preferably in writing, to senior
management and the board of trustees or its audit committee. [SAS 60]
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FSP Section 21,500
Auditors9Reports on Audits Performed Under
Government Auditing Standards and OMB
Circular A-133 Checklist1
.01 This checklist has been developed by the staff of the Technical Information Division of the AICPA as a
nonauthoritative practice aid.
.02 This checklist has two parts: Part I is for reports on audits performed under Government Auditing
Standards ("Yellow Book"). Part II contains the additional requirements for reports on audits performed in
accordance with OMB Circular A-133. For audits performed under Circular A-133, both Parts I and II of this
checklist must be completed.
.03 Explanation of References:

A-133 =

Office of Management and Budget (OMB) Circular A-133

GAS =

Government Auditing Standards ("Yellow Book," issued by GAO, 1988 Revision)

SAS =

AICPA Statement on Auditing Standards

AU =

Reference to section number in AICPA Professional Standards (vol. 1)

SOP 92-9 =

AICPA Statement of Position, Audits of Not-for-Profit Organizations Receiving Federal
Awards

.04 Checklist Questionnaire
Yes

No

N/A

a. A report on the provider's basic financial statements? 2
b. A report on internal control structure?

_____
_____

_____
_____

_____
_____

c. A report on compliance with laws and regulations that may have a direct and
material effect on the basic financial statements?
[SOP 92-9, par. 7.2]

_____

_____

_____

Part I—Reports on Audits Performed in Accordance with Government
Auditing Standards (the “Yellow Book")
1. In an audit performed in accordance with the Yellow Book, are the following
reports issued:

1 On March 8, 1990, The Office of Management and Budget issued Circular A-133, Audits of Institutions of Higher Education and Other
Nonprofit Organizations, to implement a "single audit" requirement for not-for-profit institutions. Circular A-133 requires that the auditor
perform the audit in accordance with Government Auditing Standards (the "Yellow Book") issued by the Comptroller General of the United
States.
Circular A-133, which supersedes the audit provisions of Circular A-110, is effective for audits of fiscal years beginning on or after January 1,
1990. Because Circular A-133 permits biennial audits, some institutions may not be required to follow its requirements until the audits of their
financial statements for the fiscal year ending June 30,1992.
SAS No. 68, Compliance Auditing Applicable to Governmental Entities and Other Recipients of Governmental Financial Assistance,
provides guidance on planning, performing, and reporting on the compliance aspects of audits in accordance with GAAS, GAO Standards,
Circular A-133, and Circular A-128, which applies to State and Local Governmental entities.

On December 28,1992, the AICPA issued SOP 92-9, Audits of Not-for-Profit Organizations Receiving Federal Awards, to provide guidance
on the auditor's responsibilities when conducting an audit in accordance with Circular A-133. It incorporates the guidance in SAS 68, SOP
92-7, OMB's October 1991 Compliance Supplement for Audits of Institutions of Higher Learning and Other Nonprofit Institutions, and the
President's Council on Integrity and Efficiency Standards Subcommittee's Position Statement No. 6 (A-133 Questions and Answers).
2 See the checklist for auditor's reports on the basic financial statements.
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Yes

No

N/A

2. Does each auditor's report listed in Step 1. above contain a statement that the
audit is conducted in accordance with generally accepted auditing standards and
the Yellow Book?
[GAS, Ch. 5, par. 3; SOP 92-9, par. 7.4]
Report on Internal Control Structure 3

3. Does the report on internal control structure include, at a minimum:
a. The scope of the auditor's work to obtain an understanding of the internal
control structure, and to assess control risk?
b. The significant internal controls established to ensure compliance with laws
and regulations that have a material impact on the financial statements?

c. Any reportable conditions, including separate identification of material
weaknesses, identified as a result of the auditor's work in understanding and
assessing the control risk?

d. A statement that the report is intended for the information of the audit
committee, management, and specific legislative or regulatory bodies, but
that this restriction is not intended to limit the distribution of the report, if a
matter of public record?
[GAS, Ch. 5, pars. 17 and 18; SAS 68, pars. 33 and 40 (AU 801.33 and .40);
SOP 92-9, Appendix D, Exhibit D-3]

4. If the auditor notes reportable conditions in the financial statement audit, does
the auditor's report on the internal control structure also contain:
a. The definition of reportable conditions?

b. A description of the reportable conditions noted?
c. The definition of material weakness?
d. If applicable, a statement that other matters involving the internal control
structure and its operation were communicated to management in a separate
letter?
[SAS 68, par. 40 (AU 801.40)]

5. If material weaknesses are noted in the report, does the auditor disclose the
condition, cause, criteria, and effect of those material weaknesses?
[GAS, Chap. 5, par. 9, fn. 7]
6. If the auditor determines that deficiencies in the internal control structure are not
significant enough to be considered reportable conditions (referred to as
"nonreportable conditions"), are those matters communicated to the provider in
writing (or orally, with working paper documentation)?
[SAS 68, par. 39 (AU 801.39); GAS Chap. 5, par. 25]
7. If the auditor issues a separate written communication describing nonreportable
conditions, does the auditor's report on the internal control structure refer to that
separate communication?
[SAS 68, pars. 38 and 39 (AU 801.38—.39); SOP 92-9, par. 7.12]
8. If no reportable conditions are noted during the audit, does the report disclose
that no material weaknesses were identified?
[SAS 68, par. 42 (AU 801.42); SOP 92-9, par. 7.11]
Report on Compliance with Laws and Regulations

9. Does the report on compliance with laws and regulations conform to the standard
report illustrated in SAS 68, paragraph 25 (AU 801.25)?
10. If the auditor decides not to test compliance with laws and regulations, does the
report contain a statement that compliance with laws and regulations was not
tested?
[SAS 68, par. 26 (AU 801.26); GAS, Chap. 5, par. 6]

3 Under the Yellow Book, a report on the internal control structure is required in all audits, even if no reportable conditions were noted. [SAS
68, par. 33 (AU 801.33)]
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Yes

11. If the auditing procedures disclose material instances of noncompliance, is the
report on compliance appropriately modified?
a. Does that modified report include:
(1) The definition and identification of material instances of noncompliance
noted?
(2) A statement that the noncompliance noted was considered in forming an
opinion on whether the provider's financial statements are presented
fairly, in conformity with GAAP?
[SAS 68, par. 27 (AU 801.27)]
12. If the report contains material instances of noncompliance, is a statement
considered about:
a. Whether the misstatements were corrected?
or

--------

_____

--------

_____

b. The effect of such misstatements on the auditor's report on the basic financial
statements?
[SAS 68, par. 28 (AU 801.28)]

--------

13. Are immaterial instances of noncompliance reported in a separate
communication to the provider? 4
[SAS 68, pars. 29 and 95 (AU 801.29 and .95); GAS, Chap. 5, par. 8]

--------

14. If the auditor issues a separate letter describing immaterial instances of
noncompliance, does the compliance report include a reference to that letter?
[SAS 68, pars. 29 and 30 (AU 801.29 and .30); SOP 92-9, par. 7.16]

--------

15. If the auditor becomes aware of illegal acts that could result in criminal
prosecution, are they communicated in a separate report to management?
[SAS 68, par. 31 (AU 801.31); GAS Chap. 5, par. 5]
16. If the auditor becomes aware of illegal acts and remains uncertain about whether
they will materially affect the financial statements, is the report on the financial
statements qualified or a disclaimer of opinion issued?
[SOP 92-9, par. 7.18]

Other Matters
17. If performance audits are required by contractual obligations, are findings
presented in accordance with the guidance in the Yellow Book?
[GAS, Ch. 2, pars. 6—10]
18. If the auditor is unable to follow an applicable standard and is unable to
withdraw from the engagement, does the auditor disclose in the scope section of
the report the fact that an applicable standard is not followed, the reasons
therefor, and the known effect of not following the standard on the results of the
audit?
[GAS, Ch. 3, par. 27]
19. Does the auditor's report disclose the status of known but uncorrected significant
or material findings and recommendations from prior audits that could have an
effect on the current audit objective?
[SAS 68, par. 20, fn. 10 (AU 801.20); GAS, Ch. 3, par. 41; SOP 92-9, par.7.41]
20. Does the auditor's report disclose in the scope section of the report audit scope
impairments and the known effects they might have on the results of the audit?
[GAS, Ch. 3, par. 42]
21. Does the auditor consider the impact of his or her report on the financial
statements of the effects of noncompliance findings from other simultaneous
audits that may result in claims for refunds?
[SOP 92-9, par. 7.43; SFAS 5 (AC C59)]

--------

--------

--------

--------

--------

--------

--------

4 If there are no immaterial instances of noncompliance, the auditor may so note in the report. [SOP 92-9, par. 7.24]
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No

N/A

Yes

No

N/A

22. Do the reports on the schedule of federal awards, compliance, and internal
control structure carry the same date as the report on the basic financial
statements?
[SOP 92-9, par. 7.27]

Part II—Reports on Audits Performed Under OMB Circular A-133
1. If the provider is subject to the requirements of Circular A-133, are the following
additional reports issued:

a. A report on a supplementary schedule of the provider's federal awards? 5
b. A report on the internal control policies and procedures used to administer
federal awards?

c. A report on compliance with specific laws and regulations that may have a
direct and material effect on each major program?
d. A report on compliance with certain laws and regulations applicable to
nonmajor programs? 6
e. A report on compliance with general requirements? 7
[SOP 92-9, par. 7.19]

2. Does each auditor's report listed in Step 1. above contain a statement that the
audit is conducted in accordance with generally accepted auditing standards;
Government Auditing Standards, issued by the Comptroller General of the
United States; and Office of Management and Budget (OMB) Circular A-133?
[SOP 92-9, Appendix D, Exhibits D-8 through D-18]
3. Does the auditor's report on the provider's schedule of federal awards:
a. Identify major programs?
b. Show total expenditures for each program?
[A-133, item 15c(1)]
Report on Internal Control Structure

4. Does the report on internal control structure include:
a. A description of the scope of the auditor's work to test the internal control
structure policies and procedures?
b. A description of the provider's significant control policies and procedures
established to provide reasonable assurance that it is managing its federal
awards in compliance with applicable laws and regulations?
[SOP 92-9, par. 7.22]

5. If the auditor determines that tests of controls are likely to be ineffective in
preventing or detecting noncompliance, is that matter disclosed as a "reportable
condition?"
[SOP 92-9, par. 7.23]

6. If the auditor limits his or her consideration of the internal control structure for
any reason, are the circumstances disclosed in the report on the internal control
structure?
[SOP 92-9, par. 7.23]
Report on Compliance With Specific Requirements Related to Major Programs

7. For audits of major programs, does the report on compliance with specific
requirements conform to the standard report illustrated in SAS 68, paragraph 81
(AU 801.81)?
5 Under Circular A-133, a recipient or subrecipient of an award is required to prepare a schedule of federal awards. A sample schedule is
presented in the Illustrative Financial Statements section of these checklists. [Attachment to Circular A-133, par. 15(c)(1), SOP 92-9, pars. 4.7
and 7.20]
6 Under the Yellow Book, a report on the internal control structure is required in all audits even if no reportable conditions were noted. [SAS
68, par. 33 (AU 801.33)]
7 A report on compliance with general requirements is required regardless of whether there are any major programs. [SOP 92-9, par. 7.25]
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Yes

8. If the auditor is disclaiming an opinion due to a scope limitation:
a. Are the reasons indicated, in a separate paragraph, as to why the audit did
not comply with generally accepted auditing standards, Government
Auditing Standards, or OMB Circular A-133?

_____

b. Does the auditor state that the scope of the audit is not sufficient to warrant
the expression of an opinion?

_____

c. Does the auditor disclose any reservations he or she has regarding compliance
with applicable laws and regulations?
[SAS 68, pars. 82 and 84 (AU 801.82 and .84)]
9. If the auditor expresses a qualified or adverse opinion due to material
noncompliance on a major federal program, does the auditor state the basis for
such an opinion in the report?
[SAS 68, par. 85 (AU 801.85)]

_____

_____

10. If the auditing procedures disclose instances of noncompliance on major
programs:
a. Did the resulting modification to the auditor's report on compliance consider
factors that include:
(1) The number and types of instances of noncompliance?

_____

(2) Determinability of questioned costs?

_____

(3) Materiality of questioned costs?

_____

b. If, after considering those factors, the auditor concludes that the instances of
noncompliance have a material effect on a federal program, is a qualified or
adverse opinion issued?
or

c. If, after considering those factors, the auditor is unable to determine if the
instance of noncompliance could have a material effect on the program, does
the report state noncompliance occurred but the effect on the programs
presently cannot be determined?

_____

_____

d. Is the effect of uncertainties associated with federal programs on the basic
financial statements considered and, if necessary, is the report modified?
[SOP 92-9, par. 7.24]

_____

11. If the auditor is unable to examine appropriate evidence to support the comply/
noncomply decision, is the report appropriately modified?
[SOP 92-9, par. 7.24]

_____

Report on Compliance with General Requirements

12. Does the report on compliance with general requirements conform to the
standard report illustrated in SAS 68, paragraph 52 (AU 801.52) and in Exhibits
D-15 through D-17 in Appendix D of SOP 92-9?

_____

Report on Compliance Related to Nonmajor Programs

13. For nonmajor programs, does the report on compliance conform to the standard
report illustrated in SAS 68, paragraph 90 (AU 801.90) and in Exhibit D-18 in
Appendix D of SOP 92-9?

_____

General
14. Does the auditor's report on compliance with laws and regulations include, for
each federal award:
a. An identification of total amounts questioned as a result of noncompliance?
b. Any corrective action recommended by the auditor?
[SOP 92-9, pars. 7.30 and 7.32]

15. Are any immaterial findings included either (1) in a schedule of findings and
costs or (2) in a separate communication to management?
[SOP 92-9, par. 7.30]
41

_____
_____

_____

No

N/A

Yes

16. If the audit is biennial, are both years within the period covered?
[SOP 92-9, par. 2.47]
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No

N/A

FSP Section 21,600
Illustrative Financial Statements
.01 The following illustrative auditors' reports and financial statements demonstrate the practical applications
of the reporting practices discussed in the AICPA Audit and Accounting Guide, Audits of Providers of Health Care
Services (the Guide). Specific types of health care organizations have been selected to illustrate a wide diversity of
reporting practices; it is not intended that these illustrations represent either the only types of disclosure or the
only statement formats that would be appropriate. Health Care Organizations are urged to develop financial
statement formats that are appropriate for their individual circumstances while being consistent with the
accounting and reporting practices discussed in the Guide.
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SAMPLE HOSPITAL

.02

Balance Sheets
(Disaggregated "Layered" Reporting Approach)

December 31,19X7 and 19X6
Assets

19X7

General Funds
Current assets
Cash and cash equivalents.............. $ 3,103,000
Assets whose use is limited—
required for current liabilities
(notes 5, 7, and 8).........................
970,000
Patient accounts receivable, net of
estimated uncollectibles of
$2,500,000 in 19X7 and
$2,400,000
in 19X6 (note 15)...........................
15,100,000
Estimated third-party payor
settlements—Medicare
(notes 3 and 15)...........................
441,000
Supplies, at lower of cost
(first-in, first-out) or market....
1,163,000

Other current assets.........................
Due from donor-restricted funds ..

Total current assets..................

Assets whose use is limited (notes 5,
7, and 8)
By board for capital improvements
By agreements with third-party
payors for funded depreciation .
Under malpractice funding
arrangement—held by trustee ..
Under indenture agreement—
held by trustee...............................
Total assets whose use is
limited......................................
Less assets whose use is limited
and that are required for current
liabilities..........................................
Noncurrent assets whose use
is limited..................................
Property and equipment, net (notes
6 and 7)
Other assets
Prepaid pension cost (note 12)....
Deferred financing costs..................
Investment in affiliated company
(note 4).............................................
Total other assets......................

Liabilities and Fund Balances

19X6

$

Current liabilities
Current installments of long-term
debt (note 7).................................... $
Current portion of capital lease
obligations (note 7)......................
Accounts payable.............................
Accrued expenses.............................

4,525,000

1,300,000

600,000
938,000
403,000
500,000

21,098,000

22,460,000

11,000,000

10,000,000

9,234,000

6,151,000

3,007,000

2,682,000

11,708,000

11,008,000

34,949,000

29,841,000

970,000

1,300,000

33,979,000

28,541,000

51,038,000

50,492,000

85,000
693,000

35,000
759,000

917,000
1,695,000
$107,810,000

576,000
1,370,000
$102,863,000

970,000

19X6

$

1,200,000

500,000
2,217,000
3,396,000

550,000
2,085,000
3,225,000

2,143,000

1,942,000

200,000
122,000

210,000
632,000

600,000

500,000

955,000

772,000

Due to donor-restricted funds ....

300,000

—

Total current liabilities...........

11,403,000

11,116,000

Deferred third-party
reimbursement .............................

746,000

984,000

Estimated malpractice costs, net of
current portion (note 8)................

3,207,000

2,182,000

Long-term debt, excluding current
installments (note 7)....................

22,644,000

23,614,000

Capital lease obligations,
excluding current portion (note
7)........................................................
Fund balance......................................

500,000
69,310,000

400,000
64,567,000

$107,810,000

$102,863,000

Estimated third-party payor
settlements—Medicaid (note 2) .
Deferred third-party
reimbursement .............................
Advances from third-party payors
Current portion of estimated
malpractice costs (note 8)...........
Retainage and construction
accounts payable...........................

14,194,000

321,000
—

19X7

Commitments and contingent
liabilities (notes 3, 6, 8,12, and

13)
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SAMPLE HOSPITAL
Balance Sheets—continued

.02

(Disaggregated "Layered" Reporting Approach)
December 31,
Assets

Donor-Restricted Funds
Specific-purpose funds
Cash......................................................$
Investments, at cost that
approximates market ..................
Grants receivable .........................

$
Plant replacement and expansion
funds
Cash......................................................
Investments, at cost that
approximates market ..................
Pledges receivable, net of
estimated uncollectibles of
$60,000 in 19X7 and $120,000
in 19X6.............................................
Due from general funds..................

$
Endowment funds
Cash......................................................
Investments, net of $175,000
valuation allowance in 19X7,
market value $3,798,000 in
19X7 and $5,013,000 in 19X6
(note 9).............................................
Due from general funds..................

$

378,000

$

1,719,000

$

321,000

252,000

165,000

132,000
150,000

380,000
—

558,000

$

653,000

3,856,000
150,000

5,320,000
100,000
$

$

Due to general funds..................
Fund balance...............................

866,000

1,253,000

5,259,000

Fund balance.................................

1,368,000

24,000

19X7

Accounts payable........................ ... $
Deferred grant revenue...............
Due to general funds....................

378,000
455,000
535,000

728,000
613,000

and 19X6
Liabilities and Fund Balances

19X6

19X7

Fund balance...............................
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$

72,000
—
255,000
1,041,000

1,719,000

$

1,368,000

345,000
521,000

558,000

$

5,259,000

866,000
6,073,000

5,259,000

$

See accompanying notes to financial statements.

205,000
92,000
—
1,422,000

558,000

$

6,073,000

19X6

$

6,073,000

SAMPLE HOSPITAL

Balance Sheets

.03

(Aggregated Approach)
December 31,19X7 and 19X6
Assets

19X7

19X6

970,000

1,267,000

1,372,000

Current portion of capital lease obli
gations (note 7) ...............................

500,000

550,000

15,100,000

14,194,000

Accounts payable ...............................
2,422,000
Accrued expenses.......
3,396,000
Estimated third-party payor settle
ments—Medicaid (note 2).
2,143,000

2,157,000
3,225,000

$

441,000

600,000

Supplies, at lower of
cost (first-in,
first-out) or market.........................

1,163,000

938,000

Other current assets.............................

321,000

Total current assets.........................

403,000

Deferred third-party reimbursement
Advances from third-party payors..
Current portion of
estimated malpractice
costs (note 8) ....................................
Retainage and construction ac
counts payable..................................
Advances and deferred revenue....

21,095,000

22,532,000

Total current liabilities ..................

11,000,000

10,000,000

9,234,000

6,151,000

Deferred third-party reimbursement..
Estimated malpractice costs, net of
current portion (note 8)......................
Long-term debt, excluding current in
stallments (note 7)...............................

3,007,000

2,682,000

11,708,000

11,008,000

2,277,000

1,634,000

5,259,000

6,073,000

Total assets whose use is limited or
restricted.............................................

42,485,000

37,548,000

Less assets whose use is limited and
that are required for current liabili
ties............................................................

1,267,000

1,372,000

Noncurrent assets whose use is lim
ited or restricted...............................

41,218,000

36,176,000

Property and equipment, net (notes 5
and 6)......................................................

51,038,000

50,492,000

85,000
693,000

35,000
759,000

917,000
1,695,000

576,000
1,370,000

$115,046,000

$110,570,000

Other assets

Prepaid pension cost (note 12).........
Deferred financing costs....................
Investment in affiliated company
(note 4)...............................................
Total other assets.............................

19X6

5,025,000

2,803,000

Estimated third-party
payor settlements
—Medicare (notes
3 and 15)...........................................

Assets whose use is limited
or restricted (notes 5,
7, 8 and 9)
By board for capital improvements .
By agreements with third-party
payors for funded depreciation ..
Under malpractice funding arrange
ment—held by trustee..................
Under indenture agreement—held
by trustee...........................................
By donors or grantors for specific
purposes.............................................
By donors for permanent endow
ment funds........................................

19X7

Current liabilities
Current installments of long-term
debt (note 7)........................................ $

Current assets

Cash and cash equivalents................ $
Assets whose use is limited—re
quired for current liabilities (notes
5,7 and 8)...........................................
Patient accounts receivable, net of
estimated uncollectibles of
$2,500,000 in 19X7 and
$2,400,000 in 19X6 (note 15) ....

__________ Liabilities and Fund Balances__________

$

1,200,000

1,942,000

200,000
122,000

210,000
632,000

600,000

500,000

955,000
92,000

772,000
—

11,400,000

11,188,000

746,000

984,000

3,207,000

2,182,000

22,644,000

23,614,000

Capital lease obligations, excluding
current installments (note 7)..............

500,000

400,000

Total liabilities.............................

38,497,000

38,368,000

Net assets
Unrestricted..........................................

69,310,000

64,567,000

Temporarily restricted by donors/
grantors...............................................

1,980,000

1,562,000

Permanently restricted by donors ..
Total net assets.............................

5,259,000
76,549,000

6,073,000
72,202,000

$115,046,000

$110,570,000

Commitments and contingent lia
bilities (notes 3, 6, 8,12 and 13)
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SAMPLE HOSPITAL
04

Statements of Revenue and Expenses of General Funds
Years Ended December 31,19X7 and 19X6
19X7

19X6

Net patient service revenue (notes 3,7 and 15).....................................
Other revenue................................................................................................

$92,656,000
6,010,000

$88,942,000
5,380,000

Total revenue ....................................................................................

98,666,000

94,322,000

Expenses (notes 7, 8,12, and 13)
Professional care of patients....................................................................
Dietary services .........................................................................................
General services.........................................................................................
Administrative services...........................................................................
Employee health and welfare.................................................................
Medical malpractice costs........................................................................
Depreciation and amortization of property and equipment............
Interest .........................................................................................................
Provision for bad debts.............................................................................

53,016,000
4,407,000
10,888,000
11,075,000
10,000,000
1,125,000
4,782,000
1,752,000
1,010,000

48,342,000
4,087,000
9,973,000
10,145,000
9,335,000
200,000
4,280,000
1,825,000
1,103,000

Total expenses....................................................................................

98,055,000

89,290,000

Income from operations.................................................................

611,000

5,032,000

Nonoperating gains (losses)
Unrestricted gifts and bequests (note 10).............................................
Loss on investment in affiliated company (note 4) ..........................
Income on investments of endowment funds...................................
Income on investments whose use is limited
By board for capital improvements...................................................
By agreements with third-party payors for funded depreciation
Under indenture agreement...............................................................
Other investment income........................................................................

1,120,000
850,000
100,000
284,000

1,050,000
675,000
90,000
226,000

Nonoperating gains, net.................................................................

3,889,000

3,601,000

Revenue and gains in excess of expenses and losses............................

$ 4,500,000

$ 8,633,000

See accompanying notes to financial statements.
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822,000
(37,000)
750,000

926,000
(16,000)
650,000

SAMPLE HOSPITAL

.05

Statements of Changes in Fund Balances
Years Ended December 31,19X7 and 19X6
19X7

19X6

Donor-Restricted Funds

General
Funds

SpecificPurpose
Funds

Balances at beginning of year............. . $64,567,000 $1,041,000

Additions
Revenue and gains in excess of
expenses and losses....................... .
Gifts, grants, and bequests
(notes 10 and 11)............................
Investment income............................ .
Net realized gain on sale
of investments.................................
Transfer to finance property
and equipment additions.............

4,500,000
—
—

869,000
62,000

$ 521,000

—

General
Funds

SpecificPurpose
Funds

$6,073,000 $56,679,000 $ 933,000

—

8,633,000

220,000
20,000

—
—

—
—

—

558,000
50,000

Plant
Replacement
and Expan Endowment
Funds
sion Funds

$ 501,000

$5,973,000

—

—

290,000
15,000

—

—

100,000

—

—

—

20,000

243,000

—

(243,000)

—

255,000

—

(255,000)

97,000

—

8,888,000

4,743,000
Deductions
Provision for uncollectible pledges .
Capital contribution to Sample
Health System (note 11)............... .
Net realized loss on sale
of investments................................. .
Unrealized loss on marketable
equity securities (note 9).............
Transfer to other revenue...............

—

Donor-Restricted Funds

Plant
Replacement
and Expan Endowment
sion Funds
Funds

931,000

—

—

60,000

—

—

—

—

—

—

—

—

639,000

—

—
—

175,000
—

—
—

—
—

—
550,000

—

550,000

60,000

Balances at end of year......................... . $69,310,000 $1,422,000

$ 558,000

See accompanying notes to financial statements.
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814,000

—
1,000,000

1,000,000

608,000

70,000

—
—
100,000

—
100,000

—

50,000

—

—

—

—

—

—

—

—
—

—
—

—
500,000

500,000

50,000

$5,259,000 $64,567,000 $1,041,000

$ 521,000

—

$6,073,000

SAMPLE HOSPITAL
.06

Statements of Cash Flows of General Funds (Direct Method) *
Years Ended December 31,19X7 and 19X6
19X7

19X6

Cash flows from operating activities and gains and losses
Cash received from patients and third-party payors........................................ $ 90,342,000 $ 85,619,000
(81,510,000)
Cash paid to employees and suppliers................................................................ (89,214,000)
5,563,000
Other receipts from operations.............................................................................
6,042,000
905,000
1,122,000
Receipts from unrestricted gifts and bequests...................................................
2,330,000
2,510,000
Interest and dividends received.............................................................................
(1,780,000)
(1,856,000)
Interest paid (net of amount capitalized)...........................................................
9,022,000

11,051,000

(4,728,000)

(5,012,000)

243,000
(394,000)

(4,798,000)

255,000
(425,000)
(1,000,000)
(855,000)

Net cash used by investing activities ..............................................................

(9,677,000)

(7,037,000)

Cash flows from financing activities
Increase in retainage and construction accounts payable...............................
Repayment of long-term debt...............................................................................
Payments from donor-restricted funds related to temporary loans.............
Payments on capital lease obligations ................................................................
Temporary loans from (to) donor-restricted funds..........................................

183,000
(1,200,000)
500,000
(550,000)
300,000

175,000
(1,630,000)

Net cash used by financing activities..............................................................

(767,000)

(2,248,000)

Net increase (decrease) in cash and cash equivalents..........................................
Cash and cash equivalents at beginning of year...................................................

(1,422,000)
4,525,000

Net cash provided by operating activities and gains and losses...............

Cash flows from investing activities
Purchase of property and equipment..................................................................
Transfer from donor-restrictea fund for purchase of property and
equipment..............................................................................................................
Investment in affiliated company.........................................................................
Transfer to Sample Health System......................................................................
Cash invested in assets whose use is limited.....................................................

Cash and cash equivalents at end of year................................................................ $ 3,103,000

(600,000)
(193,000)

1,766,000
2,759,000
$ 4,525,000

See accompanying notes to financial statements.

* The direct and indirect methods of reporting cash flows by hospitals are presented for illustrative purposes. The indirect method is
presented on page 21,609.
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SAMPLE HOSPITAL

.06

Statements of Cash Flows of General Funds (Direct Method) *—continued
Years Ended December 31,19X7 and 19X6

Reconciliation of Revenue and Gains in Excess of Expenses and Losses to Net
Cash Provided by Operating Activities and Gains and Losses
19X7

19X7

Revenue and gains in excess of expenses and losses........... .................................
Adjustments to reconcile revenue and gains in excess of expenses and
losses to net cash provided by operating activities and gains and losses
Depreciation and amortization of property and equipment......................
Provision for bad debts........................................................................................
Amortization of deferred financing costs.......................................................
Loss on investment in affiliated company.....................................................
Noncash gifts and bequests...............................................................................
Decrease in amounts due to third-party payors............................................
Increase in liability for estimated malpractice costs.....................................
Increase in patient accounts receivable...........................................................
Increase in supplies and other current assets................................................
Increase in accounts payable and accrued expenses...................................
Increase in interest earned but not received on assets whose use is
limited................................................................................................................
Net cash provided by operating activities and gains and losses

4,500,000

$ 8,633,000

4,782,000
1,010,000
66,000
53,000
—
(398,000)
1,125,000
(1,916,000)
(193,000)
303,000

4,280,000
1,103,000
45,000
—
(175,000)
(77,000)
200,000
(3,141,000)
(118,000)
301,000

—

(310,000)
$ 9,022,000

$ 11,051,000

Supplemental Disclosures of Cash Flow Information

Sample Hospital entered into capital lease obligations of $600,000 for new equipment in 19X7.

See accompanying notes to financial statements.

* The direct and indirect methods of reporting cash flows by hospitals are presented for illustrative purposes. The indirect method is
presented on page 21,609.
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Statements of Cash Flows of General Funds (Indirect Method) *
Years Ended December 31,19X7 and 19X6
19X7

19X6

Cash flows from operating activities and gains and losses
Revenue and gams in excess of expenses and losses........................................ $ 4,500,000 $ 8,633,000
Adjustments to reconcile revenue and gains in excess of expenses and
losses to net cash provided by operating activities and gains and losses
Depreciation and amortization of property and equipment..................
4,280,000
4,782,000
Provision for bad debts...................................................................................
1,103,000
1,010,000
Amortization of deferred financing costs...................................................
45,000
66,000
—
Loss on investment in affiliated company................................................
53,000
Noncash gifts and bequests...........................................................................
—
(175,000)
Decrease in net amounts due to third-party payors.................................
(398,000)
(77,000)
Increase in liability for estimated malpractice costs.................................
1,125,000
200,000
Increase in patient accounts receivable.......................................................
(1,916,000)
(3,141,000)
Increase in supplies and other current assets............................................
(193,000)
(118,000)
Increase in accounts payable and accrued expenses...............................
303,000
301,000
Increase in interest earned but not received on assets whose use is
limited....................................................................................................................
—
(310,000)
Net cash provided by operating activities and gains and losses...........

9,022,000

11,051,000

(4,728,000)

(5,012,000)

243,000
(394,000)
—
(4,798,000)

255,000
(425,000)
(1,000,000)
(855,000)

Net cash used by investing activities .............................................................

(9,677,000)

(7,037,000)

Cash flows from financing activities
Increase in retainage and construction accounts payable...............................
Repayment of long-term debt...............................................................................
Payments from donor-restricted funds related to temporary loans.............
Payments on capital lease obligation..................................................................
Temporary loans from (to) donor-restricted funds..........................................

183,000
(1,200,000)
500,000
(550,000)
300,000

175,000
(1,630,000)
—
(600,000)
(193,000)

Net cash used by financing activities..............................................................

(767,000)

(2,248,000)

Cash flows from investing activities
Purchase of property and equipment..................................................................
Transfer from donor-restricted fund for purchase of property and
equipment..............................................................................................................
Investment in affiliated company.........................................................................
Transfer to Sample Health System......................................................................
Cash invested in assets whose use is limited.....................................................

Net increase (decrease) in cash and cash equivalents..........................................
(1,422,000)
1,766,000
Cash and cash equivalents at beginning of year...................................................
2,759,000
4,525,000
Cash and cash equivalents at end of year................................................................ $ 3,103,000 $ 4,525,000
Supplemental Disclosures of Cash Flow Information

Sample Hospital entered into capital lease obligations of $600,000 for new equipment in 19X7.

Cash paid for interest (net of amount capitalized) in 19X7 and 19X6 was $1,780,000 and $1,856,000,
respectively.

See accompanying notes to financial statements.
* The direct and indirect methods of reporting cash flows by hospitals are presented for illustrative purposes. The direct method is presented
on pages 21,607 and 21,608.
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Notes to Financial Statements

.08

December 31,19X7 and 19X6
1.

Summary of Significant Accounting Policies
Organization
Sample Hospital (Hospital) is a not-for-profit acute care hospital. Effective June 30, 19X6, under a plan of
reorganization, Sample Health System was formed as the parent holding company of the Hospital. In its
capacity as sole member of the Hospital, Sample Health System has the right to appoint Hospital trustees,
approve major Hospital expenditures, and approve long-term Hospital borrowings.

Charity care
The Hospital provides care to patients who meet certain criteria under its charity care policy without charge or
at amounts less than its established rates. Because the Hospital does not pursue collection of amounts
determined to qualify as charity care, they are not reported as revenue.

Income taxes

The Hospital is a not-for-profit corporation as described in Section 501(c)(3) of the Internal Revenue Code
and is exempt from federal income taxes on related income pursuant to Section 501(a) of the Code.
Net patient service revenue
Net patient service revenue is reported at the estimated net realizable amounts from patients, third-party
payors, and others for services rendered, including estimated retroactive adjustments under reimbursement
agreements with third-party payors. Retroactive adjustments are accrued on an estimated basis in the period
the related services are rendered and adjusted in future periods as final settlements are determined.

Investments and investment income
Donated investments are reported at fair value at the date of receipt, which is then treated as cost. Marketable
equity securities included in investment portfolios are carried at the lower of aggregate cost (determined on an
average-cost basis) or market at the balance sheet date. Other marketable securities are stated at cost, adjusted
for impairments in value that are deemed to be other than temporary. Sample Hospital's investment in
Affiliated Company is reported on the equity method of accounting that approximates Sample Hospital's
equity in the underlying net assets of Affiliated Company.
Investment income on proceeds of borrowings that are held by a trustee, to the extent not capitalized, and
investment income on assets deposited in the malpractice trust are reported as other revenue. Investment
income from all other general fund investments and investment income of endowment funds are reported as
nonoperating gains. Investment income and gains (losses) on investments of donor-restricted funds are added
to (deducted from) the appropriate restricted fund balance.

Pledges
Pledges, less an allowance for uncollectible amounts, are recorded as receivables in the year made. Un
restricted pledges are reported in the statement of revenue and expenses of general funds; restricted pledges
are reported as additions to the appropriate restricted fund balance.

Statement of revenue and expenses of general funds
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For purposes of display, transactions deemed by management to be ongoing, major, or central to the
provision of health care services are reported as revenues and expenses. Peripheral or incidental transactions
are reported as gains and losses.

Costs of borrowing
Interest cost incurred on borrowed funds during the period of construction of capital assets is capitalized as a
component of the cost of acquiring those assets.

Deferred financing costs are amortized over the period the obligation is outstanding using the interest
method.
Amortization of deferred financing costs is capitalized during the period of construction of capital assets.

Donor-restricted funds

Donor-restricted funds are used to differentiate resources, the use of which is restricted by donors or grantors,
from resources of general funds on which donors or grantors place no restriction or that arise as a result of the
operations of the Hospital for its stated purposes. Restricted gifts and other restricted resources are recorded
as additions to the appropriate restricted fund.
Resources restricted by donors for plant replacement and expansion are added to the general fund balance to
the extent expended within the period.

Resources restricted by donors or grantors for specific operating purposes are reported in other operating
revenue to the extent used within the period.

Assets whose use is limited
Assets whose use is limited include assets set aside by the Board of Trustees for future capital improvements,
over which the Board retains control and may at its discretion subsequently use for other purposes; assets set
aside in accordance with agreements with third-party payors; and assets held by trustees under indenture
agreements and self-insurance trust arrangements.

Property and equipment
Property and equipment acquisitions are recorded at cost. Property and equipment donated for hospital
operations are recorded as additions to the donor-restricted plant replacement and expansion funds at fair
value at the date of receipt and as transfers to the general fund balance when the assets are placed in service.

Depreciation is provided over the estimated useful life of each class of depreciable asset and is computed on
the straight-line method. Equipment under capital leases is amortized on the straight-line method over the
shorter period of the lease term or the estimated useful life of the equipment. Such amortization is included in
depreciation and amortization in the financial statements.

An accelerated method for depreciating certain operating equipment acquired before 1970 has been elected
for third-party reimbursement purposes. Third-party reimbursement is deferred to the extent of the effect of
the difference between accelerated depreciation used for reimbursement reporting and straight-line deprecia
tion used for financial reporting.
Cash and cash equivalents

Cash and cash equivalents include investments in highly liquid debt instruments with a maturity of three
months or less, excluding amounts whose use is limited by board designation or other arrangements under
trust agreements or with third-party payors.
Estimated malpractice costs
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The provision for estimated self-insured medical malpractice claims includes estimates of the ultimate costs
for both reported claims and claims incurred but not reported.

2.

Charity Care

The Hospital maintains records to identify and monitor the level of charity care it provides. These records
include the amount of charges foregone for services and supplies furnished under its charity care policy, the
estimated cost of those services and supplies, and equivalent service statistics. The following information
measures the level of charity care provided during the years ended December 31,19X7 and 19X6.
19X7

19X6

Charges foregone, based on established rates ......................................................... $6,000,000 $5,700,000
Estimated costs and expenses incurred to provide charity care .......................... 5,600,000 5,000,000
Equivalent percentage of charity care patients to all patients served ...............
5.7%
5.6%

3.

Net Patient Service Revenue

The Hospital has agreements with third-party payors that provide for payments to the Hospital at amounts
different from its established rates. A summary of the payment arrangements with major third-party payors
follows.
•

Medicare. Inpatient acute care services rendered to Medicare program beneficiaries are paid at prospec
tively determined rates per discharge. These rates vary according to a patient classification system that is
based on clinical, diagnostic, and other factors. Inpatient nonacute services, certain outpatient services,
and defined capital and medical education costs related to Medicare beneficiaries are paid based upon a
cost reimbursement methodology. The Hospital is reimbursed for cost reimbursable items at a tentative
rate with final settlement determined after submission of annual cost reports by the Hospital and audits
thereof by the Medicare fiscal intermediary. The Hospital's classification of patients under the Medicare
program and the appropriateness of their admission are subject to an independent review by a peer
review organization under contract with the Hospital. The Hospital's Medicare cost reports have been
audited by the Medicare fiscal intermediary through December 31,19X6.

•

Medicaid. Inpatient and outpatient services rendered to Medicaid program beneficiaries are reimbursed
under a cost reimbursement methodology. The Hospital is reimbursed at a tentative rate with final
settlement determined after submission of annual cost reports by the Hospital and audits thereof by the
Medicaid fiscal intermediary. The Hospital's Medicaid cost reports have been audited by the Medicaid
fiscal intermediary through December 31,19X6.

•

Blue Cross. Inpatient services rendered to Blue Cross subscribers are reimbursed at prospectively
determined rates per day of hospitalization. The prospectively determined per diem rates are not subject
to retroactive adjustment.

The Hospital has also entered into payment agreements with certain commercial insurance carriers, health
maintenance organizations, and preferred provider organizations. The basis for payment to the Hospital
under these agreements includes prospectively determined rates per discharge, discounts from established
charges, and prospectively determined daily rates.
4.

Investment in Affiliated Company
In 19X2, the Hospital entered into an agreement with two unrelated hospitals to establish and operate an
ambulatory care center, Affiliated Company (Center). In accordance with this agreement, each hospital
invested $970,000 for a 33⅓ percent equity interest in the common stock of the Center. The investment was
made in installments during the years 19X5 through 19X7, and in May 19X7 the Center began operations. The
investment is recorded on the equity method.
Summarized financial information from the unaudited financial statements of the Center follows.
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December 31,19X7

.. $1,779,000
.. 4,052,000
.. 1,566,000
.. 1,514,000
.. 2,751,000

Current assets .........
Noncurrent assets ..
Current liabilities ...
Noncurrent liabilities
Shareholders' equity

December 31,19X6

$1,835,000
4,007,000
1,325,000
2,789,000
1,728,000

Year Ended
December 31,19X7

.. $3,220,000
(111,000)

Revenue
Net loss

December 31,19X6

$2,899,000
(48,000)

Assets Whose Use Is Limited

Assets whose use is limited that are required for obligations classified as current liabilities are reported in
current assets. The composition of assets whose use is limited at December 31,19X7 and 19X6, is set forth in
the following table. Investments are stated at cost that approximates market.
19X7

19X6

$11,000,000

$10,000,000

By agreements with third-party payors for funded depreciation
Cash and short-term investments .................................................................... $ 8,503,000
316,000
U.S. Treasury obligations....................................................................................
415,000
Interest receivable.................................................................................................

$ 5,712,000
316,000
123,000

$ 9,234,000

$ 6,151,000

By board for capital improvements
Cash and short-term investments

Under malpractice funding arrangement—held by trustee
Cash and short-term investments .................................................................... $ 1,058,000
1,949,000
U.S. Treasury obligations....................................................................................

$

857,000
1,825,000

$ 3,007,000

$ 2,682,000

Under indenture agreement—held by trustee
Cash and short-term investments .................................................................... $ 592,000
U.S. Treasury obligations.................................................................................... 11,024,000
92,000
Interest receivable.................................................................................................

$ 1,260,000
9,674,000
74,000

$11,708,000

$11,008,000

Property and Equipment

A summary of property and equipment at December 31,19X7 and 19X6, follows.
19X7

19X6

Land............................................................................................................................. $ 3,000,000
472,000
Land improvements .................................................................................................
Buildings and improvements................................................................................. 46,852,000
Equipment.................................................................................................................. 29,190,000
2,851,000
Equipment under capital leases.............................................................................

$ 3,000,000
472,000
46,636,000
26,260,000
2,752,000

Less accumulated depreciation and amortization ............................................

82,365,000
34,928,000

79,120,000
30,661,000

Construction in progress ........................................................................................

47,437,000
3,601,000

48,459,000
2,033,000

Property and equipment, net............................................................................. $51,038,000

$50,492,000
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Construction contracts of approximately $7,885,000 exist for the remodeling of Hospital facilities. At Decem
ber 31,19X7, the remaining commitment on these contracts approximated $4,625,000.
7.

Long-Term Debt and Capital Leases
A summary of long-term debt and capital leases at December 31,19X7 and 19X6, follows,
19X7

19X6

9.25% Revenue Notes, due November 1,19XX, collateralized by a pledge
of the Hospital's gross receipts .........................................................................$21,479,000

$22,016,000

9.25% mortgage loan, due January 19XX, collateralized by a mortgage on
property and equipment with a depreciated cost of $1,800,000 at
December 31,19X7..............................................................................................

2,010,000

2,127,000

9.75% note payable, due March 19XX, unsecured ..........................................

125,000

671,000

Total long-term debt........................................................................................

23,614,000

24,814,000

Less current installments of long-term debt.......................................................

970,000

1,200,000
$23,614,000

Long-term debt excluding current installments ....................................... $22,644,000

Capital lease obligations, at varying rates of imputed interest from 9.8% to
12.3%, on leased equipment with an amortized cost of $1,500,000 at
December 31,19X7 ..............................................................................................

1,000,000

950,000

Less current portion of capital lease obligations ..............................................

500,000

550,000

Capital lease obligations, excluding current portion ........................................$

500,000

$

400,000

Under the terms of the Revenue Note Indenture, the Hospital is required to maintain certain deposits with a
trustee. Such deposits are included with assets whose use is limited in the financial statements. The Revenue
Note Indenture also places limits on the incurrence of additional borrowings and requires that the Hospital
satisfy certain measures of financial performance as long as the notes are outstanding.
Scheduled principal repayments on long-term debt and payments on capital lease obligations for the next five
years are as follows:

19X8
19X9
19Y0
19Y1
19Y2

Less amount representing interest on obligations under capital
leases .......................................................................................................

Long-Term
Debt

Obligations Under
Capital Leases

$ 970,000
912,000
983,000
1,060,000
1,143,000

$ 500,000
260,000
260,000
95,000

$5,068,000

1,115,000
115,000
$1,000,000
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A summary of interest cost and investment income on borrowed funds held by the trustee under the Revenue
Note Indenture during 19X7 and 19X6 follows.
19X7

$ 740,000
1,825,000

$2,492,000

$2,565,000

505,000
330,000

663,000
386,000

$ 835,000

$1,049,000

Investment income
Capitalized .......................................................................................................
Credited to other revenue .............................................................................

8.

19X6

Interest cost
Capitalized ....................................................................................................... $ 740,000
Charged to operations ................................................................................... 1,752,000

Medical Malpractice Claims

The Hospital is uninsured with respect to medical malpractice risks. Losses from asserted claims and from
unasserted claims identified under the Hospital's incident reporting system are accrued based on estimates
that incorporate the Hospital's past experience, as well as other considerations including the nature of each
claim or incident and relevant trend factors. Accrued malpractice losses have been discounted at rates ranging
from 7 percent to 9 percent. No accrual for possible losses attributable to incidents that may have occurred but
that have not been identified under the incident reporting system has been made because the amount is not
reasonably estimable.
The Hospital has established an irrevocable trust fund for the payment of medical malpractice claim
settlements. Professional insurance consultants have been retained to assist the Hospital with determining
amounts to be deposited in the trust fund.
9.

Endowment Funds—Investments
Donor-restricted endowment fund investment portfolios include marketable equity securities that are carried
at the lower of cost or market. Marketable equity securities of endowment funds at December 31, 19X7 and
19X6, are summarized as follows:
Cost

19X7 ......... ............................... $1,476,000
19X6 ......... ............................... 1,620,000

Quoted Market
Value

$1,301,000
1,832,000

Gross Unrealized
Gains

Gross Unrealized
Losses

8,000
228,000

$183,000
16,000

$

Realized gains on marketable equity securities of endowment funds amounted to $10,000 in 19X7 and
$50,000 in 19X6.
10. Assets Held in Trust

The Hospital is an income beneficiary of the Thomas A. Smith Trust. Because the assets of the trust are not
controlled by the Hospital, they are not included in the Hospital's financial statements. At December 31,
19X7, the market value of the assets totaled approximately $2,652,000. Distributions of income are made at
the discretion of the trustees. Income distributed to the Hospital by the trust is restricted for construction or
equipment additions and amounted to $150,000 in 19X7 and $140,000 in 19X6.

11. Related Party Transactions
Because of the existence of common trustees and other factors, the Hospital and Sample Health Foundation
(Foundation) are related parties. The Foundation is authorized by the Hospital to solicit contributions on its
behalf. In its general appeal for contributions to support the community's providers of health care services,
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the Foundation also solicits contributions for certain other health care institutions. In the absence of donor
restrictions, the Foundation has discretionary control over the amounts, timing, and use of its distributions.
Contributions made by the Foundation to the Hospital during the years ended December 31, 19X7 and 19X6,
are reported in the Hospital's financial statements as follows:
19X7

19X6

Unrestricted gifts and bequests ............................................................................. $375,000
Restricted contributions for—
Specific purposes................................................................................................. 300,000
Plant replacement and expansion ..................................................................
70,000

$525,000
200,000
85,000

In addition, the Hospital made a capital contribution of $1,000,000 to Sample Health System during 19X6.
12. Pension Plan

The Hospital has a defined benefit pension plan covering substantially all of its employees. The plan benefits
are based on years of service and employee compensation during the last five years of covered employment.
The Hospital makes annual contributions to the plan equal to the amounts of net periodic pension cost.
Contributions are intended to provide not only for benefits attributed to service to date but also for those
expected to be earned in the future.
The actuarially computed net periodic pension cost for 19X7 and 19X6 included the following components:
19X7

19X6

Service cost-benefits earned during the period ............................................ $ 905,000
700,000
Interest cost on projected benefit obligation ................................................
Actual return on plan assets ............................................................................. (950,000)
70,000
Net amortization and deferral...........................................................................

$ 725,000

Net periodic pension cost

$ 770,000
650,000
(800,000)
80,000

$ 700,000

Assumptions used in the accounting for net periodic pension cost were as follows:
As of December 31
19X7

19X6

Discount rates .................................................................................................................. 7.0%
Rates of increase in compensation levels .................................................................. 6.0
Expected long-term rate of return on assets ............................................................. 8.0

7.0%
6.0
8.0

The following table sets forth the plan's funded status and amounts recognized in the Hospital's financial
statements at December 31,19X7 and 19X6.
19X7

19X6

Actuarial present value of benefit obligations
Vested benefit obligation ................................................................................. . $ 8,020,000
1,900,000
Nonvested benefit obligation........................................................................... .

$ 6,800,000
1,930,000

Accumulated benefit obligation..................................................................
Effect of projected future compensation levels........................................ .

9,920,000
1,000,000

8,730,000
980,000

Projected benefit obligation ......................................................................... .
Plan assets at fair value (primarily listed stocks and U.S. bonds)............... .

10,920,000
11,050,000

9,710,000
9,800,000

Plan assets in excess of projected benefit obligation .......................... .
Unrecognized net gain from past experience different from that assumed
Prior service cost not yet recognized in net periodic pension cost...........
Unrecognized net asset at January 1,19X6, being recognized
over 15 years ..................................................................................................... .
Prepaid pension cost, included in other assets in the balance sheet .... . $
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130,000
(30,000)
50,000

90,000
(40,000)
55,000

(65,000)

(70,000)

85,000

$

35,000

13. Commitments

Leases that do not meet the criteria for capitalization are classified as operating leases with related rentals
charged to operations as incurred.

The following is a schedule by year of future minimum lease payments under operating leases as of December
31,19X7, that have initial or remaining lease terms in excess of one year.
Year Ending
December 31

Minimum Lease
Payments

19X8............................................................................................................................................. $ 517,000
19X9 .............................................................................................................................................
506,000
19Y0 .............................................................................................................................................
459,000
19Y1 .............................................................................................................................................
375,000
19Y2 .............................................................................................................................................
343,000
Total minimum lease payments.................................................................................................$2,200,000
Total rental expense in 19X7 and 19X6 for all operating leases was approximately $859,000 and $770,000,
respectively.

14. Subsequent Event

On February 9, 19X8, the Hospital signed a contract in the amount of $1,050,000 for the purchase of certain
real estate.
15. Concentrations of Credit Risk

The Hospital is located in Feeling, Illinois. The Hospital grants credit without collateral to its patients, most of
whom are local residents and are insured under third-party payor agreements. Revenues from patients and
third-party payors were as follows:
19X7

Medicare and Medicaid .................................................................................................
Blue Cross .........................................................................................................................
Other third-party payors
(none over 10%) .........................................................................................................
Patients .............................................................................................................................
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19X6

20%
20

19%
19

27
33

26
36

100%

100%

SAMPLE NURSING HOME, INC.

Balance Sheets

.09

December 31,19X2 and 19X1
19X2

Assets
Current assets
Cash and cash equivalents
Investments, at cost that
approximates market
Assets whose use is limited—
required for current liabilities

Patient accounts receivable less
allowance for doubtful accounts:
19X2-$6,700; 19X1-$5,300
Estimated third-party payor
settlements
Interest receivable
Supplies
Prepaid expenses
Total current assets
Assets whose use is limited
Under indenture agreement—held
by trustee

By board for capital improvements
Total assets whose use is limited
Less assets whose use is limited
and that are required for current
liabilities
Noncurrent assets whose use
is limited
Property and equipment
Land
Land improvements
Buildings
Furniture, fixtures, and equipment
Less accumulated depreciation
Property and equipment, net
Other assets
Note receivable
Bond issuance cost, net of
accumulated amortization of
$38,000 in 19X2 and
$32,000 in 19X1
Land held for investment
Total other assets
Total assets

$

95,000

$ 129,000

150,000

—

50,000

Liabilities and Shareholders'Equity
Current liabilities
Current maturities of long-term debt
Accounts payable
Accrued expenses
Deposits from patients
Income taxes payable

19X1

50,000

152,000

71,000
7,000
59,000
3,000

62,000
—
57,000
2,000

597,000

452,000

176,000

153,000

47,000

47,000
200,000

223,000

$ 50,000
52,000
188,000
45,000
15,000

Deferred income tax liability

6,000

14,000

Long-term debt, less current
maturities

1,700,000

1,750,000

Shareholders' equity
Common stock, $20 par value;
authorized 5,000 shares; issued
and outstanding 3,500 shares

Retained earnings
Total shareholders' equity

50,000

50,000

173,000

150,000

205,000
37,000
1,399,000
228,000
1,869,000
210,000
1,659,000

205,000
32,000
1,399,000
189,000
1,825,000
141,000
1,684,000

81,000

72,000

42,000
27,000
150,000
$2,579,000

48,000
7,000
127,000

Total liabilities and shareholders'
equity

$2,413,000

See accompanying notes to financial statements.
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19X1

50,000
78,000
175,000
50,000
74,000
427,000

Total current liabilities

162,000

19X2
$

350,000

70,000

70,000

376,000
446,000

229,000
299,000

$2,579,000

$2,413,000

SAMPLE NURSING HOME, INC.

.10

Statements of Income and Retained Earnings
Years Ended December 31,19X2 and 19X1
19X2

19X1

Net patient service revenue................................................................................................................ $2,163,000
67,000
Other revenue........................................................................................................................................

$1,949,000
22,000

Total revenue ...............................................................................................................................

2,230,000

1,971,000

Expenses
Nursing services...............................................................................................................................
Dietary services..................................................................................................................................
General services...............................................................................................................................
Administrative services..................................................................................................................
Interest.................................................................................................................................................
Provision for bad debts ..................................................................................................................
Depreciation......................................................................................................................................

1,083,000
228,000
212,000
173,000
164,000
92,000
69,000

1,010,000
225,000
212,000
147,000
172,000
83,000
57,000

Total expenses...............................................................................................................................

2,021,000

1,906,000

Income from operations..............................................................................................................
Nonoperating gains-interest and dividends...................................................................................

209,000
18,000

65,000
7,000

Income before provision for income taxes.............................................................................
Provision for income taxes..................................................................................................................

227,000
80,000

72,000
29,000

Net income....................................................................................................................................
Retained earnings at beginning of year..........................................................................................

147,000
229,000

43,000
186,000

Retained earnings at end of year....................................................................................................... $ 376,000

$ 229,000

See accompanying notes to financial statements.
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SAMPLE NURSING HOME, INC.
.11

Statements of Cash Flows
Years Ended December 31,19X2 and 19X1
19X2

19X1

Cash flows from operating activities and gains
Cash received from residents and third-party payors.............................................................. $2,048,000 $1,796,000
22,000
67,000
Cash received from others..............................................................................................................
Cash paid to employees and suppliers........................................................................................ (1,679,000) (1,495,000)
10,000
10,000
Interest and dividends received.....................................................................................................
(170,000)
(160,000)
Interest paid ......................................................................................................................................
(30,000)
(29,000)
Taxes paid..........................................................................................................................................
15,000
35,000
Deposits received from patients ...................................................................................................
(20,000)
(30,000)
Deposits refunded to patients.......................................................................................................

Net cash provided by operating activities and gains...........................................................
Cash flows from investing activities
Purchase of land held for investment..........................................................................................
Purchase of other investments .....................................................................................................
Proceeds from sale of property.....................................................................................................
Additions to property and equipment ........................................................................................
Cash invested in assets whose use is limited.............................................................................
Increase in notes receivable............................................................................................................

262,000

128,000

(20,000)
(150,000)
(44,000)
(23,000)
(9,000)

2,000
(79,000)

Net cash used in investing activities........................................................................................

(246,000)

(77,000)

Cash flows from financing activities
Repayment of long-term debt.......................................................................................................

(50,000)

(50,000)

Net cash used by financing activities......................................................................................

(50,000)

(50,000)

Net increase (decrease) in cash..........................................................................................................
Cash at beginning of year..................................................................................................................

(34,000)
129,000

1,000
128,000

Cash at end of year................................................................................................................................$

95,000

$ 129,000

147,000

43,000

69,000
92,000
6,000

(8,000)

57,000
83,000
6,000
11,000
7,000

(44,000)

(79,000)

Reconciliation of Net Income to Net Cash Provided by Operating Activities and Gains

Net income.............................................................................................................................................
Adjustments to reconcile net income to net cash provided by
operating activities and gains
Depreciation..................................................................................................................................
Provision for bad debts ..............................................................................................................
Amortization..................................................................................................................................
Loss on disposal of property.....................................................................................................
Increase (decrease) in deferred income tax liability..............................................................
Net effect of changes in receivables, supplies, prepaid expenses,
accounts payable, accrued expenses, and deposits.........................................................

Net cash provided by operating activities and gains........................................................... $ 262,000
See accompanying notes to financial statements.
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$ 128,000

SAMPLE NURSING HOME, INC.

.12

Notes to Financial Statements
December 31,19X2 and 19X1

1.

Summary of Significant Accounting Policies
Sample Nursing Home, Inc. (Company) operates a 128-bed nursing home in Abacus, New State. A summary
of the Company's significant accounting policies follows.

Income taxes

The provisions for income taxes are based on net income reported for financial reporting purposes. Deferred
income taxes arise from temporary differences between financial and income tax reporting of various items
(principally depreciation). Tax credits are treated as a reduction of the provision for income taxes in the year
in which the credits arise.

Patient service revenue
Patient service revenue is reported at the estimated net realizable amounts from residents, third-party payors,
and others for service rendered.

Revenue under third-party payor agreements is subject to audit and retroactive adjustment. Provisions for
estimated third-party payor settlements are provided in the period the related services are rendered.
Differences between the estimated amounts accrued and interim and final settlements are reported in
operations in the year of settlement.

Assets whose use is limited
Assets set aside by the board of directors for capital improvements and assets limited as to use under terms of
a note indenture are classified as assets whose use is limited.

Property and equipment
Property and equipment are recorded at cost. Depreciation is calculated on the straight-line method over the
estimated useful lives of depreciable assets.

Bond issuance costs
Costs incurred in issuing bonds are being amortized over the term of the bonds using the straight-line
method.

Cash and cash equivalents
Cash and cash equivalents include investments in highly liquid debt instruments with a maturity of three
months or less, excluding amounts whose use is limited by board designation or note indenture.
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2.

Assets Whose Use Is Limited

Assets whose use is limited under a note indenture agreement at December 31, 19X2 and 19X1, are
summarized as follows:
19X1

19X2

U.S. Treasury obligations, at cost that approximates market........................................ $150,000
23,000
Cash..........................................................................................................................................
3,000
Accrued interest income.......................................................................................................

$130,000
21,000
2,000

$176,000

$153,000

Assets set aside by the board of directors for capital improvements consist of certificates of deposit, at a cost
that approximates market.
3.

Long-Term Debt

Long-term debt at December 31,19X2 and 19X1, was as follows:
19X1

19X2

9.5 percent notes payable to the City of Abacus, maturing $50,000
annually through November 1,19XX, with a final maturity of $1,000,000
on November 1, 20XX.............................................................................................. . $1,750,000
50,000
Less current maturities.................................................................................................

$1,800,000
50,000

$1,700,000

$1,750,000

The notes are collateralized by a first-mortgage lien on all property and equipment of the Company and a
security interest in all of its receipts. The note indenture requires the maintenance of certain deposits with a
trustee, which are included in assets whose use is limited.

Future maturities of long-term debt as of December 31,19X2, follow.

19X3................................................................................................................................................... $ 50,000
50,000
19X4...................................................................................................................................................
50,000
19X5...................................................................................................................................................
50,000
19X6...................................................................................................................................................
50,000
19X7...................................................................................................................................................
Thereafter.......................................................................................................................................... 1,500,000
$1,750,000

Total
4.

Income Taxes
The provisions for income taxes on earnings were as follows:
19X2

19X1

Current
Federal............................................................................................................................. $72,000
2,000
State .................................................................................................................................

$15,000

Total current..............................................................................................................

74,000

15,000

Deferred
Federal.............................................................................................................................
State ..................................................................................................................................

6,000

13,000
1,000

Total deferred............................................................................................................

6,000

14,000

Total provision for income taxes................................................................................... $80,000

$29,000
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A reconciliation between the "statutory" federal income tax rate and the effective rate in the statements of
income is as follows:

5.

19X2

19X1

Statutory tax rate.......................................................................................................................... 34%
State taxes, net of federal benefit............................................................................................... 1

40%
1

Effective tax rate............................................................................................................................ 35%

41%

Pension Plan
[The disclosures contained in this note would be similar to the disclosures contained in note 12 of Sample
Hospital and therefore are not repeated here.]

6.

Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample
Hospital and therefore are not repeated here.]
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SAMPLE CONTINUING CARE RETIREMENT COMMUNITY

Balance Sheets

.13

December 31,19X5 and 19X4
Liabilities and Fund Deficit

19X4

19X5

Assets

19X4

19X5

187,000

197,000

Current liabilities
Current maturities of long-term debt
Accounts payable..................................
Accrued expenses..................................
Deposits on unoccupied units...........

Supplies...................................................
Prepaid expenses..................................

40,000
15,000

21,000
8,000

Total current liabilities....................

453,000

469,000

Total current assets...........................

617,000

556,000
Long-term debt, less current maturities

8,871,000

8,935,000

2,130,000

1,753,000

Current assets
Cash.......................................................... $
Accounts receivable (net of allow
ance for doubtful accounts of
$4,000 and $5,000 ...........................

Assets whose use is limited
Under note agreement—investments
By board for capital improvements—
investments.............................................

375,000

$

330,000

$

90,000
180,000
161,000
22,000

$

77,000
174,000
178,000
40,000

100,000

65,000

2,230,000

1,818,000

Refundable fees........................................

59,000

144,000

Property and equipment
Land..........................................................
Land improvements.............................
Buildings and improvements..............
Furniture and equipment....................

557,000
205,000
14,573,000
752,000

557,000
203,000
14,564,000
698,000

Estimated obligation to provide future
services and use of facilities in excess
of amounts received or to be re
ceived for such services......................

88,000

100,000

Accumulated depreciation..................

16,087,000
1,194,000

16,022,000
742,000

Deferred revenue from advance fees ..

9,304,000

9,585,000

14,893,000

15,280,000

Fund deficit.................................................
Deferred financing costs (net of accu
mulated amortization of $28,000
and $21,000)...........................................

83,000

90,000

$17,823,000

$17,744,000

(952,000)

$17,823,000

See accompanying notes to financial statements.
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(1,489,000)

$17,744,000

SAMPLE CONTINUING CARE RETIREMENT COMMUNITY
.14

Statements of Revenue and Expenses and Changes in Fund Deficit
Years Ended December 31,19X5 and 19X4
19X5

Revenue
Resident fees earned including amortization of deferred revenue from nonrefundable
advance fees of $935,000 and $915,000............................................................................... $ 3,946,000
Patient revenue from nonresidents............................................................................................
249,000
Investment income.........................................................................................................................
107,000
Other.................................................................................................................................................
75,000
4,377,000

Expenses
Resident care....................................................................................................................................
Dietary...............................................................................................................................................
Healthcare......................................................................................................................................
Plant .................................................................................................................................................
General and administrative.........................................................................................................
Depreciation....................................................................................................................................
Interest ............................................................................................................................................

19X4

$ 3,152,000
275,000
78,000
68,000
3,573,000

649,000
781,000
185,000
491,000
436,000
452,000
967,000
3,961,000
416,000

566,000
701,000
170,000
421,000
445,000
447,000
955,000
3,705,000
(132,000)

Decrease (increase) in obligation to provide future services and use of facilities to
current residents.........................................................................................................................

12,000

(82,000)

Income (loss) from operations............................................................................................
Nonoperating gains—Contributions............................................................................................

428,000
109,000

(214,000)
73,000

Revenue and gains in excess of (less than) expenses.....................................................
Fund deficit, beginning of year.......................................................................................................

537,000
(1,489,000)

(141,000)
(1,348,000)

Fund deficit, end of year.................................................................................................................. $ (952,000) $(1,489,000)

See accompanying notes to financial statements.
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SAMPLE CONTINUING CARE RETIREMENT COMMUNITY

.15

Statements of Cash Flows
Years Ended December 31,19X5 and 19X4
19X4

19X5

Cash flows from operating activities and nonoperating gains
Cash received from residents and third-party payors........................................................... $ 3,252,000 $ 2,341,000
75,000
68,000
Other receipts from operations...................................................................................................
73,000
109,000
Investment income received.......................................................................................................
78,000
107,000
Contributions received..................................................................................................................
(2,042,000)
Cash paid to employees and suppliers...................................................................................... (2,589,000)
(950,000)
945,000)
Interest paid....................................................................................................................................
Net cash provided (used) by operating activities and nonoperating gains.............

Cash flows from investing activities
Acquisition of property and equipment....................................................................................
Cash invested in assets whose use is limited...........................................................................
Assets whose use is limited used for acquisition of property and equipment..................

(427,000)

4,000

(250,000)
(238,000)
467,000

(65,000)
(412,000)
477,000

(21,000)

615,000
(46,000)
26,000
(77,000)

857,000
(52,000)
(307,000)

Net cash provided by financing activities.........................................................................

518,000

498,000

Net increase in cash...........................................................................................................................
Cash at beginning of year................................................................................................................

45,000
330,000

50,000
280,000

Cash at end of year ........................................................................................................................... $

375,000

Net cash used by investing activities...............................................................................
Cash flows from financing activities
Proceeds from advance fees and deposits...............................................................................
Refunds of advance fees and deposits......................................................................................
Proceeds from issuance of long-term debt...............................................................................
Repayments of long-term debt

$

330,000

Reconciliation of Revenue and Gains in Excess of (Less Than) Expenses to Net Cash
Provided (Used) by Operating Activities and Nonoperating Gains

Revenue and gains in excess of (less than) expenses ................................................................
Adjustments to reconcile revenue and gains in excess of (less than) expenses to net cash
provided (used) by operating activities and nonoperating gains
Amortization of advance fees............................................................................................
Loss (gain) on obligation to provide future services.....................................................
Depreciation and amortization..........................................................................................
Provision for bad debts .......................................................................................................
Net change in other assets and liabilities [details omitted for editorial brevity*] ..
Net cash provided (used) by operating activities and nonoperating
gains.................................................................................................................................... $

537,000

(141,000)

(935,000)
(12,000)
459,000
3,000
(48,000)

(915,000)
82,000
475,000
3,000
69,000

4,000

$ (427,000)

See accompanying notes to financial statements.

* FASB Statement 95, Statement of Cash Flows, paragraph 29 [AC C25.127], requires that "The reconciliation of net income to net cash flow
from operating activities ... shall separately report all major classes of reconciling items".
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Notes to Financial Statements
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December 31,19X5 and 19X4
1.

Summary of Significant Accounting Policies
Sample Continuing Care Retirement Community (CCRC) provides housing, health care, and other related
services to residents through the operation of a retirement facility containing 249 apartments and a seventyeight-bed health care facility. A summary of significant accounting policies follows.

Advance fees
Fees paid by a resident upon entering into a continuing care contract, net of the portion thereof that is
refundable to the resident, are recorded as deferred revenue and are amortized to income using the straightline method over the estimated remaining life expectancy of the resident.
Obligation to provide future services and use of facilities
CCRC annually calculates the present value of the net cost of future services and use of facilities to be
provided to current residents and compares that amount with the balance of deferred revenue from advance
fees. If the present value of the net cost of future services and use of facilities exceeds the deferred revenue
from advance fees, a liability is recorded (obligation to provide future services and use of facilities to current
residents) with the corresponding charge to income. The obligation is discounted at 9 percent, based on the
expected long-term rate of return on government obligations.

Investments
Investments, which consist of U.S. Treasury obligations, are stated at cost, which approximates fair market
value. Interest and investment income are recognized when earned.

2.

Property and Equipment
Property and equipment are stated at cost. Donated property is recorded at its estimated fair value at date of
receipt, which then is treated as cost. Depreciation is computed on the straight-line method based on the
following estimated useful lives:

Land improvements ............................................................................................................................................... 20 years
Buildings and improvements...............................................................................................................................
40 years
Furniture and equipment........................................................................................................................................5-15 years
When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed
from the accounts, and any resulting gain or loss is recognized in income for the period. The cost of
maintenance and repairs is expensed as incurred; significant renewals and betterments are capitalized.
3.

Deferred Financing Costs

Deferred financing costs are being amortized using the interest method over the term of the related financing
agreement.

4.

Tax Status

CCRC is a not-for-profit corporation as described in Section 501(c)(3) of the Internal Revenue Code and is
exempt from federal income taxes pursuant to Section 501(a) of the Internal Revenue Code.
5.

Long-Term Debt
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Long-term debt at December 31, 19X5 and 19X4, is as follows:
19X5

10.75% mortgage note payable........................................ ...................................$8,901,000
34,000
Notes payable to bank—unsecured................................. .................................
26,000
Other...................................................................................... .................................
8,961,000
90,000
Less current maturities....................................................... .................................
$8,871,000

19X4

$8,965,000
14,000
33,000
9,012,000
77,000
$8,935,000

The mortgage note is payable in consecutive monthly installments of principal and interest of $85,425 to May
20XX. The note is collateralized by a first mortgage on property and equipment with a depreciated value at
December 31,19X5, of $14,893,000 and by a pledge of all operating revenue.

As required by the mortgage note agreement, CCRC established an initial debt service reserve fund of
$1,000,000 at April 15, 19X3. All resident fees received thereafter, net of resident fee refunds and debt service
payments not to exceed $300,000 annually in the first four years and $200,000 annually thereafter, are to be
added to the debt service reserve fund until the total sum of $2,050,000 is accumulated. Since June 1, 19X4,
CCRC is required to deliver to the Trustee $5,500 per month to establish maintenance reserves until the
aggregate of such payments equals a residential unit reserve and a health care center reserve of $240,000 and
$90,000, respectively. At December 31, 19X5, the trustee held investments aggregating $2,130,000. Such
amount had been classified as assets whose use is limited.

Scheduled annual principal maturities of long-term debt for the next five years are as follows:

19X6............................................................................................................................................................................. $
19X7 ..............................................................................................................................................................................
19X8 ..............................................................................................................................................................................
19X9 ................................................................................................................................................................................
19Y0 ................................................................................................................................................................................
6.

90,000
90,000
95,000
105,000
105,000

Assets Whose Use Is Limited
[The disclosures contained in this note would be similar to the disclosures contained in Note 5 of Sample
Hospital and therefore are not repeated here.]

7.

Pension Plan
[The disclosures contained in this note would be similar to the disclosures contained in Note 12 of Sample
Hospital and therefore are not repeated here.]

8.

Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in Note 15 of Sample
Hospital and therefore are not repeated here.]
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SAMPLE HOME HEALTH AGENCY

Balance Sheets
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December 31,19X5 and 19X4
Assets

Current assets
Cash and cash equivalents... $
Investments...............................
Accounts receivable, net of
estimated uncollectibles of
$61,000 in 19X5 and
$30,000 in 19X4 ..................

19X4

19X5

74,000

$ 41,000

112,000

102,000

752,000

476,000

Liabilities and Fund Balance

19X5

Current liabilities
Current maturities of long
term debt (note 4).................... $

19X4

13,000

$ 13,000

40,000

21,000

496,000

352,000

28,000

31,000

70,000

66,000

Other receivables....................

27,000

22,000

Accounts payable....................
Accrued payroll and vacation
costs........................................
Estimated third-party payor
settlements (note 2).............
Advances from third-party
payors........................................

Total current assets..................

965,000

641,000

Total current liabilities...........

647,000

483,000

Assets whose use is limited
(note 3)
Cash............................................
Bank certificates of deposit ..

35,000
100,000

35,000
100,000

135,000

135,000
Long-term debt less current
maturities (note 4)....................

105,000

118,000

Equipment
Medical and office equipment
Vehicles.....................................

Less accumulated
depreciation..........................
Net equipment ....................
Deferred finance charges, net of
accumulated amortization of
$15,000 in 19X5 and $10,000
in 19X4........................................

56,000
50,000

39,000
37,000

106,000

76,000

45,000

24,000

61,000

52,000

20,000

25,000

$1,181,000

$853,000

Fund balance.................................

See accompanying notes to financial statements.
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429,000

252,000

$1,181,000

$853,000

SAMPLE HOME HEALTH AGENCY

.18

Statements of Revenue and Expenses and Changes in Fund Balances
Years Ended December 31,19X5 and 19X4
19X5

Net patient service revenue (note 2)................................................................................................. $4,042,000
Other revenue........................................................................................................................................
27,000

19X4

$2,687,000
32,000

Total revenue.........................................................................................................................

4,069,000

2,719,000

Expenses (note 5)
Professional care of patients .........................................................................................................
General and administrative............................................................................................................
■ Occupancy..........................................................................................................................................
Provision for bad debts ..................................................................................................................
Depreciation......................................................................................................................................
Interest.................................................................................................................................................

2,714,000
1,042,000
90,000
46,000
21,000
16,000

1,835,000
675,000
83,000
21,000
15,000
19,000

Total expenses....................................................................................................................... 3,929,000

2,648,000

Income from operations.......................................................................................................................

140,000

71,000

Nonoperating gains.............................................................................................................................
Contributions ....................................................................................................................................
Investment income...........................................................................................................................

19,000
18,000

15,000
12,000

Total nonoperating gains...................................................................................................

37,000

27,000

Revenue and gains in excess of expenses........................................................................................
Fund balance at beginning of year ..............................................................................................

177,000
252,000

98,000
154,000

Fund balance at end of year............................................................................................................ $ 429,000

$ 252,000

See accompanying notes to financial statements.
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SAMPLE HOME HEALTH AGENCY
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Statements of Cash Flows
Years Ended December 31,19X5 and 19X4
19X4

19X5

Cash flows from operating activities and nonoperating gains
$ 2,542,000
Cash received from customers and third-party payors......................................................... $ 3,721,000
32,000
Other receipts from operations...................................................................................................
22,000
(2,540,000)
Cash paid to employees and suppliers...................................................................................... (3,683,000)
(14,000)
Interest paid....................................................................................................................................
(11,000)
27,000
Nonoperating gains.......................................................................................................................
37,000

86,000

47,000

Cash flows from investing activities
Purchase of equipment................................................................................................................
Purchase of investments..............................................................................................................

(30,000)
(10,000)

(19,000)
(15,000)

Net cash used by investing activities ...........................................................................

(40,000)

(34,000)

Cash flows from financing activities
Payment of long-term debt..........................................................................................................

(13,000)

Net cash used by financing activities...........................................................................

(13,000)

Net cash provided by operating activities and nonoperating gains......................

Net increase in cash and cash equivalents....................................................................................
Cash and cash equivalents at beginning of year.........................................................................

33,000
41,000

Cash and cash equivalents at end of year....................................................................................$

74,000

13,000
28,000

$

41,000

Reconciliation of Revenue and Gains in Excess of Expenses to Net Cash Provided
by Operating Activities and Nonoperating Gains

98,000

Revenue and gains in excess of expenses......................................................................................
177,000
Adjustments to reconcile revenue and gains in excess of expenses to net cash provided
by operating activities and nonoperating gains
Provision for bad debts................................................................................................................
46,000
Depreciation and amortization...................................................................................................
26,000
Increase in accounts receivable...................................................................................................
(322,000)
Increase in other receivables.......................................................................................................
(5,000)
Increase in accounts payable and accrued expenses..............................................................
163,000
Decrease (increase) in estimated third-party receivables.....................................................
(3,000)
Increase in advances from third-party payors...................................................................................... 4,000

Net cash provided by operating activities and nonoperating gains
See accompanying notes to financial statements.
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$

86,000

21,000
20,000
(150,000)
(2,000)
50,000
3,000
7,000
$

47,000

SAMPLE HOME HEALTH AGENCY

Notes to Financial Statements
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Years Ended December 31,19X5 and 19X4
1.

Summary of Significant Accounting Policies
Sample Home Health Agency (the Agency) was incorporated in 19X0 as a not-for-profit corporation. The
Agency provides health and supportive services to individuals at their homes.

Charity care

The Agency has a policy of providing charity care to patients who are unable to pay. Such patients are
identified based on financial information obtained from the patient and subsequent analysis. Since the
Agency does not expect payment, estimated charges for charity care are not included in revenue.

Net patient service revenue
Net patient service revenue represents the estimated net realizable amounts from patients, third-party payors,
and others for services rendered.
Income taxes

The Agency is a not-for-profit corporation as described in Section 501(c)(3) of the Internal Revenue Code and
is exempt from federal income taxes on related income pursuant to Section 501(a) of the Code.
Assets whose use is limited
Assets set aside for board-designated purposes are classified as assets whose use is limited.

Investments
Investments consist of U.S. Treasury obligations at cost, which approximates market value.

Equipment
Equipment is recorded at cost. Depreciation is computed using the straight-line method over the estimated
useful lives of the assets.
Cash and cash equivalents

Cash and cash equivalents include investments in highly liquid debt instruments with a maturity of three
months or less, excluding amounts whose use is limited by board designation.

2.

Third-Party Rate Adjustments and Revenue
Approximately 38 percent in 19X5 and 37 percent in 19X4 of net patient service revenue was derived under
federal and state third-party reimbursement programs. These revenues are based, in part, on cost reimburse
ment principles and are subject to audit and retroactive adjustment by the respective third-party fiscal
intermediaries. In the opinion of management, retroactive adjustments, if any, would not be material to the
financial position, results of operations or cash flows of the Agency.

3.

Board-Designated Assets
The board of directors has designated cash and investments aggregating $135,000 to be used for future major
capital improvements. Those assets are classified in the balance sheets as assets whose use is limited.
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4.

Long-Term Debt
Long-term debt at December 31, 19X5 and 19X4, is as follows:
19X5

19X4

Note payable to bank, interest at 15%, collateralized by equipment with a
depreciated cost in 19X5 of $42,000................................................................ $118,000
Less current maturities..............................................................................................
13,000

$131,000
13,000

Long-term debt, less current maturities.................................................................. $105,000

$118,000

Scheduled maturities of long-term debt at December 31,19X5 are as follows:
19X6................................................................................................................................................... $ 13,000
19X7...................................................................................................................................................
13,000
19X8...................................................................................................................................................
13,000
19X9...................................................................................................................................................
13,000
19X0...................................................................................................................................................
13,000
Thereafter..........................................................................................................................................
53,000

Total
5.

$118,000

Pension Plan
[The disclosures contained in this note would be similar to the disclosures contained in note 12 of Sample
Hospital.]

6.

Charity Care
Charity care represented approximately 3 percent and 4 percent of visits in 19X5 and 19X4, respectively.

7.

Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample
Hospital.]
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SAMPLE HEALTH MAINTENANCE ORGANIZATION

Balance Sheets
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December 31,19X5 and 19X4
Assets

19X5

Current assets
2,000

$ 193,000

Temporary cash
investments.................... . 2,935,000
Premiums receivable......... .
358,000

828,000
407,000

Other receivables............... .
Supplies............................... .

263,000
190,000

261,000
184,000

Prepaid expenses............... .

197,000

Total current assets .... . 3,945,000

Cash..................................... . $

Liabilities and Fund Balance_________19X5

19X4

Current liabilities
Unsecured 12% note
payable to a bank............. $
Portion of long-term debt
payable within one year
241,000
(note 4)...............................

19X4

$

44,000

109,000

Accounts payable—medical
services ...............................

2,245,000

1,471,000

99,000

Other accounts payable and
accrued expenses.............

829,000

661,000

1,972,000

Unearned premium revenue .

141,000

202,000

Total current liabilities...........

3,456,000

2,487,000

1,436,000

Long-term debt, less portion
payable within one year
(note 4)...................................

4,295,000

4,382,000

5,756,000

5,626,000

Commitments and
contingencies (notes 2 and
8)

150,000

150,000

2,118,000

900,000

18,000

21,000

Total assets.......................... . $9,869,000

$7,769,000

Total liabilities and fund
balance............................... $9,869,000

$7,769,000

Property and equipment
(notes 3 and 4).................... . 7,559,000
Less accumulated
depreciation and
amortization.................... . 1,803,000

State guaranty fund deposit
(note 5)..................................... .
Debt issuance costs, net of
accumulated amortization
of $42,000 in 19X5 and
$39,000 in 19X4..................

7,062,000

Fund balance.............................

See accompanying notes to financial statements.
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SAMPLE HEALTH MAINTENANCE ORGANIZATION

.22

Statements of Revenue and Expenses and Changes in Fund Balances
Years Ended June 30,19X5 and 19X4
19X4

19X5

Revenue
Premiums earned.................................................................................................................... $27,682,000
Coinsurance...........................................................................................................................
689,000
Interest and other income...................................................................................................
242,000

$22,500,000
500,000
100,000

28,613,000

23,100,000

12,749,000
10,116,000
1,556,000
1,695,000
527,000
385,000
367,000

9,734,000
8,786,000
1,530,000
1,309,000
440,000
375,000
336,000

27,395,000

22,510,000

1,218,000
900,000

590,000
310,000

Expenses
Contracted hospital, physician, and other services .....................................................
Health centers—medical services......................................................................................
Health centers—administration........................................................................................
General administration.......................................................................................................
Membership services............................................................................................................
Interest....................................................................................................................................
Depreciation and amortization..........................................................................................
Income from operations .................................................................................................
Fund balance at beginning of year...................................................................................

Fund balance at end of year.............................................................................................. $ 2,118,000
See accompanying notes to financial statements.
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$

900,000

SAMPLE HEALTH MAINTENANCE ORGANIZATION
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Statements of Cash Flows
Years Ended June 30,19X5 and 19X4
19X4

19X5

Cash flows from operating activities
Cash received from premiums, stop-loss insurance recoveries, and
coinsurance .................................................................................................................. $ 28,969,000
Cash paid to employees and to providers of health care services........................ (26,405,000)
Interest received................................................................................................................
230,000
Interest paid.......................................................................................................................
(382,000)

Net cash provided by operating activities..............................................................

$ 24,410,000
(22,818,000)
90,000
(372,000)

2,412,000

1,310,000

Cash flows from investing activities
Additions to property and equipment.........................................................................

(497,000)

(121,000)

Net cash used by investing activities......................................................................

(497,000)

(121,000)

Cash flows from financing activities
Proceeds from long-term debt............................................ .........................................
Repayment of long-term debt ......................................................................................

300,000
(299,000)

(1,000,000)

Net cash provided (used) by financing activities................................................

1,000

Net increase in cash and temporary cash investments ..............................................
Beginning cash and temporary cash investments.........................................................

1,916,000
1,021,000

Ending cash and temporary cash investments..............................................................$

2,937,000

(1,000,000)

$

Reconciliation of Income From Operations to Net Cash Provided
by Operating Activities
Income from operations.................................................................................................
1,218,000
Adjustments to reconcile income from operations to net cash provided by
operating activities
Depreciation and amortization.................................................................................
370,000
Increase in accounts payable—medical services...................................................
774,000
Increase (decrease) in unearned premium revenue...................................................
(61,000)
Decrease in premiums receivable
49,000
Net effect of changes in other receivables, supplies, prepaid expenses, and
other payables.................................................................................................................
62,000

Net cash provided by operating activities......................................................... $
See accompanying notes to financial statements.
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2,412,000

189,000
832,000
1,021,000

590,000
339,000
335,000
115,000
84,000

$

(153,000)
1,310,000

SAMPLE HEALTH MAINTENANCE ORGANIZATION

Notes to Financial Statements
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June 30,19X5 and 19X4

1.

Formation and Purpose
Sample Health Maintenance Organization (Sample HMO) was incorporated in 19X0 as a not-for-profit
corporation for the purpose of providing comprehensive health care services on a prepaid basis and for the
purpose of establishing and operating organized health maintenance and health care delivery systems.

Sample HMO has been determined to be a qualified health maintenance organization (HMO) under Title XIII
of the Public Health Service Act.

2.

Summary of Significant Accounting Policies

Temporary cash investments

Temporary cash investments at June 30, 19X5 and 19X4, include a repurchase agreement with a bank and
certificates of deposit with original maturities of less than ninety days carried at a cost that is equivalent to
market.

Premiums revenue
Membership contracts are on a yearly basis subject to cancellation by the employer group or Sample HMO
upon thirty days written notice. Premiums are due monthly and are recognized as revenue during the period
in which Sample HMO is obligated to provide services to members.

Health care service cost recognition
Sample HMO contracts with various health care providers for the provision of certain medical care services to
its members. Sample HMO compensates those providers on a capitation basis. As part of a cost control
incentive program, Sample HMO retains up to XX percent of the capitation as a risk-sharing fund. In the
event of hospital utilization in excess of budget, those providers bear the risk to the extent of XX percent of the
capitation fee. Operating expenses include all amounts incurred by Sample HMO under the aforementioned
contracts.

The cost of other health care services provided or contracted for is accrued in the period in which it is
provided to a member based in part on estimates, including an accrual for medical services provided but not
reported to Sample HMO.
Inventories of supplies
Inventories of drugs and other supplies are stated at the lower of cost (first-in, first-out) or market.

Property and equipment
Property and equipment are recorded at cost, less accumulated depreciation. Maintenance and repairs are
charged to expense, and betterments are capitalized. Property and equipment costing approximately $700,000
was financed by initial development grants received in 19X1 and 19X2 from the U.S. Department of Health
and Human Services. This property will be owned by Sample HMO as long as the equipment and facilities
are used for projects related to the objectives of the Public Health Service Act.
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Depreciation is computed using the straight-line method over the estimated useful lives of the related assets
as follows:

Building.............................................................................................................................................
40 years
Improvements.................................................................................................................................. 20-25 years
Data processing and laboratory equipment and automobiles..............................................
3-7 years
Medical equipment.........................................................................................................................
10 years
Office equipment........................................................................................................................... 5-10 years
Amortization of debt issuance costs
Debt issuance costs are deferred and amortized using the interest method over the term of the related debt.
Retirement plan expense

Sample HMO has a retirement plan as more fully described in note 6. Charges to expenses are recognized
when Sample HMO makes contributions to the plan.

Federal income tax
Sample HMO is exempt from federal income taxes under Section 501(c)(4) of the Internal Revenue Code;
accordingly, no provision for federal income taxes has been made in the accompanying financial statements.
Reinsurance (stop-loss insurance)

Reinsurance premiums are reported as health care costs, and reinsurance recoveries are reported as revenue.
3.

Property and Equipment
Property and equipment at June 30,19X5 and 19X4, consists of the following:
19X5

Land................................................................................... ..................................... $ 300,000
Buildings and improvements........................................ ..................................... 5,473,000
Furniture and equipment.............................................. ..................................... 1,786,000

$ 300,000
5,459,000
1,303,000

7,559,000
1,803,000

7,062,000
1,436,000

$5,756,000

$5,626,000

Less accumulated depreciation................................... .....................................

4.

19X4

Long-Term Debt
Long-term debt is collateralized by assets with a depreciated cost at June 30, 19X5, of $4,943,000. A summary
of long-term debt at June 30,19X5 and 19X4, follows.
19X5

19X4

HHS loan, interest at 7.5%................................................... ............................... $2,020,000
HHS loan, interest at 9.25%................................................ ............................... 1,658,000
Secured equipment loans..................................................... ...............................
858,000

$2,111,000
1,694,000
686,000

4,536,000
241,000

4,491,000
109,000

$4,295,000

$4,382,000

Less portion payable within one year............................... ...............................
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Scheduled principal payments on long-term debt are as follows:
Scheduled Principal
Payments

Fiscal Year

19X6
19X7
19X8
19X9
19Y0

.............................................................................................................................................$ 241,000
.............................................................................................................................................
259,000
.............................................................................................................................................
280,000
.............................................................................................................................................
800,000
............................................................................................................................................. 2,956,000
$4,536,000

5.

State Guarantee Fund Deposit
In August 19X5 the state in which Sample HMO is domiciled enacted legislation specifically governing
HMOs. Under this legislation, Sample HMO is required to maintain a deposit of $150,000 with the director of
the division of insurance of the state.

6.

Employee Retirement Plan
Sample HMO has a contributory defined contribution retirement plan covering substantially all employees.
Expense determined in accordance with the plan formula (4 percent to 10 percent of eligible covered
compensation) was $354,000 for the year ended June 30,19X5 ($275,000 for 19X4).

7.

Stop-loss Insurance
Sample HMO has entered into a stop-loss insurance agreement with an insurance company to limit its losses
on individual claims. Under the terms of this agreement, the insurance company will reimburse Sample HMO
approximately XX percent of the cost of each member's annual hospital services, in excess of a $XXX
deductible, up to a lifetime limitation of $XXX per member. In the event Sample HMO ceases operations, (a)
plan benefits will continue for members who are confined in an acute care hospital on the date of insolvency
until their discharge and (b) plan benefits will continue for any other member until the end of the contract
period for which premiums have been paid.

Stop-loss insurance premiums of approximately $700,000 and $500,000 are included in health care costs in
19X5 and 19X4, respectively. Approximately $600,000 and $400,000 of stop-loss insurance recoveries are
deducted from health care costs in 19X5 and 19X4, respectively.

Included in other receivables is approximately $50,000 recoverable from insurers.

8.

Malpractice Claims
Malpractice claims have been asserted against Sample HMO by various claimants. The claims are in various
stages of processing, and some may ultimately be brought to trial. In the opinion of counsel, the outcome of
these actions will not have a significant effect on the financial position, results of operations or cash flows of
Sample HMO. Incidents occurring through June 30, 19X5, may result in the assertion of additional claims.
Other claims may be asserted arising from past services provided. Management believes that these claims, if
asserted, would be settled within the limits of insurance coverage.

9.

Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample
Hospital.]
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SAMPLE AMBULATORY CARE, INC.

Balance Sheets
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December 31,19X5 and 19X4
Assets

Current assets
Cash........................................$
Patient accounts receivable
less allowance for
uncollectible accounts
19X5—$15,000; 19X4—
$5,000 .................................
Estimated retroactive
adjustments—third-party
payors (note 4)..................

19X5

65,000

290,000

278,000

32,000

19,000

13,000
21,000

8,000
18,000

5,000

9,000

Total current assets.........

413,000

421,000

Property and equipment, at cost
Land..................................... .
100,000
Land improvements.........
322,000
Buildings...............................
682,000
Equipment.......................... . 1,390,000

100,000
322,000
682,000
1,389,000

2,494,000

2,493,000

217,000

100,000

Net property and
equipment ...................... . 2,277,000

2,393,000

Advances receivable (note 5)

19X5

Current liabilities
Notes payable (note 3) .... $ 138,000

76,000

$

Accounts receivable—other
Supplies.................................
Prepaid expenses and
deposits...............................

Less accumulated
depreciation....................

Liabilities and Fund Balance

19X4

19X4

$ 144,000

Accounts payable..................
Accrued payroll, benefits,
and taxes.............................
Estimated retroactive
adjustments—third-party
payors (note 4)..................
Financing advance from
third-party payor.............

52,000

87,000

33,000

22,000

30,000

24,000

Total current liabilities...

253,000

278,000

—

—

Commitment (note 5)...........

—

1,000

14,000

5,000

Fund balance.......................... .. 2,451,000

2,541,000

Total assets...................... . $2,704,000

$2,819,000

Total liabilities and fund
balance............................ .. $2,704,000

$2,819,000

See accompanying notes to financial statements.
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SAMPLE AMBULATORY CARE, INC.
26

Statements of Revenue and Expenses and Changes in Fund Balances
Years Ended December 31,19X5 and 19X4
19X5

Net patient service revenue (note 7) ............................................................. $ 860,000
Operating gains...................................................................................................
26,000
Total operating revenue and gains.....................................................

19X4

$ 357,000
14,000

886,000

371,000

425,000
77,000
107,000
177,000
34,000
27,000
15,000
117,000

184,000
54,000
52,000
109,000
22,000
1,000
17,000
100,000

979,000

539,000

Loss from operations.............................................................................
Nonoperating gain—interest income..............................................................

(93,000)
3,000

(168,000)
11,000

Expenses in excess of revenue and gains..........................................
Fund balance at beginning of period.............................................................

(90,000)
2,541,000

(157,000)
2,698,000

Expenses
Salaries and wages
Employee benefits
Supplies ...............
Purchased services
Insurance .............
Professional fees..
Interest ..................
Depreciation.........

Total expenses ........................................................................................

Fund balance at end of period ........................................................................ $2,451,000

See accompanying notes to financial statements.
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$2,541,000

SAMPLE AMBULATORY CARE, INC.
.27

Statements of Cash Flows
Years Ended December 31,19X5 and 19X4
19X5

19X4

Cash flows from operating activities and gains
Cash received from patients and third-party payors...................................................$ 866,000
$ 368,000
Cash received from others.................................................................................................
21,000
6,000
Interest received..................................................................................................................
3,000
11,000
Interest paid...........................................................................................................................
(15,000) (16,000)
Cash paid to employees and suppliers........................................................................... (870,000) (432,000)
Net cash provided from (used for) operating activities and gains....................

5,000

(63,000)

Cash flows from investing activities
Purchase of equipment.......................................................................................................
Advances made....................................................................................................................

(1,000)
(9,000)

(4,000)
(5,000)

Net cash used for investing activities......................................................................

(10,000)

(9,000)

Cash flows from financing activities
Proceeds from notes payable............................................................................................
Payments on notes payable..............................................................................................

—
(6,000)

144,000
—

Net cash provided from (used for) financing activities .....................................

(6,000)

144,000

Net increase (decrease) in cash............................................................................................
Cash at beginning of year.......................................................................................................

(11,000)
76,000

72,000
4,000

Cash at end of year.................................................................................................................. $ 65,000
Reconciliation of Expenses in Excess of Revenues and Gains to Net Cash Provided
From (Used For) Operating Activities and Gains
Net Loss
Adjustments to reconcile expenses in excess of revenues and gains to net cash
provided from (used for) operating activities and gains
Depreciation .........................................................................................................................
Provision for bad debts.......................................................................................................
Net increase in receivables and net third-party payor adjustments........................
Net decrease (increase) in inventories of supplies, prepaid expenses and
deposits .............................................................................................................................
Net increase (decrease) in accounts payable, accrued expenses and advances
from Blue Cross................................................................................................................

Net cash provided from (used for) operating activities and gains........................ $
See accompanying notes to financial statements.
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$ 76,000

(90,000)

(157,000)

117,000
14,000
(12,000)

100,000
4,000
(19,000)

1,000

(2,000)

(25,000)

11,000

5,000

$ (63,000)

SAMPLE AMBULATORY CARE, INC.

Notes to Financial Statements
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December 31,19X5 and 19X4
1.

Summary of Significant Accounting Policies

Net patient service revenue
Patient service revenue is reported at the estimated net realizable amounts from patients, third-party payors,
and others for services rendered.

Third-party contractual adjustments

Retroactively calculated third-party contractual adjustments are accrued on an estimated basis in the period
the related services are rendered. Net patient service revenue is adjusted as required in subsequent periods
based on final settlements.
Charity care
Sample Ambulatory Care, Inc. has a policy of providing charity care to patients who are unable to pay. Such
patients are identified and related charges are estimated, based on financial information obtained from the
patient and subsequent analysis. Since management does not expect payment for charity care, the estimated
charges are excluded from revenue.

Supplies
Supplies are stated at the lower of cost (first-in, first-out) or net realized value.

Depreciation

Depreciation of property and equipment is computed on the straight-line method over the estimated lives of
depreciable assets.
Investment income
Investment income and gains on investment transactions are recorded as nonoperating revenue.
2.

Formation and Scope of Operations
Sample Ambulatory Care, Inc. was incorporated on September 7, 19X3, to operate an ambulatory care health
facility to treat or prevent injury and disease, to provide funds or to expend funds to further the treatment or
prevention of injury or disease, and to develop and participate in activities designed to promote the general
health of the community.
Three area hospitals—ABC Hospital and Health Center, DEF Hospital, and GHI Hospital—entered into a
members' agreement to develop this ambulatory care center. In accordance with this agreement, each hospital
contributed capital of $947,000 to Sample Ambulatory Care, Inc.

Sample Ambulatory Care, Inc. began operations in October 19X3.
3.

Related Party Transactions
During 19X3, Sample Ambulatory Care, Inc. entered into a contract with one of the member hospitals
(managing hospital) for the management of the business and affairs of Sample Ambulatory Care, Inc. Under
this agreement, Sample Ambulatory Care, Inc. pays $4,000 per month to the managing hospital. The
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agreement with the managing hospital was to remain in effect through December 31, 19X5, but has been
extended on a month-to-month basis.

In addition, during 19X4, each hospital loaned $48,000 to Sample Ambulatory Care, Inc. in the form of
promissory notes at an interest rate of prime plus one percent (effective rates of 10 percent and 9 percent in
19X5 and 19X4, respectively). Of the total $144,000 liability, $48,000 is payable on demand after November
28,19X5, to one member hospital, with the remaining portion ($96,000) payable on demand after December
8,19X5, to the other two member hospitals. During 19X5, Sample Ambulatory Care, Inc. paid $2,000 to each
member hospital, thereby reducing the obligation to $138,000

4.

Revenue From Contracting Agencies
Sample Ambulatory Care, Inc. participates as provider of health care services to Blue Cross, Medicare, and
County Indigent Plan patients. Reimbursement for covered services is based on tentative payment rates. Final
reimbursement rates are determined after submission of annual cost reports and audits thereof by the fiscal
intermediaries. Provisions for estimated reimbursement adjustments are reported in the financial statements
in the period that the services are rendered.

5. Advances Receivable

In May 19X4 Sample Ambulatory Care, Inc. entered into a five-year agreement with XYZ Affiliates (XYZ).
Under this agreement, XYZ is to provide emergency medical services as well as charge and bill each patient
treated at Sample Ambulatory Care, Inc. Sample Ambulatory Care, Inc. has guaranteed that XYZ will collect
at least $18,000 per month during the term of this agreement. In any month in which XYZ does not collect the
minimum guarantee, Sample Ambulatory Care, Inc. advances funds to XYZ to cover the deficiency. Such
advances are to be repaid to the extent XYZ's net cash collections exceed the minimum guarantee amount.
Management estimates that the advances will be fully recovered in 19X6.

6. Income Taxes
Sample Ambulatory Care, Inc. is a not-for-profit corporation as described in Section 501(c)(3) of the Internal
Revenue Code and is exempt from federal income taxes on related income pursuant to Section 501(a) of the
Code.

7. Charity Care
Sample Ambulatory Care, Inc. has a policy of providing charity care to indigent patients in emergency
situations. These services, which are excluded from revenues, amounted to $27,000 and $13,000 in 19X3 and
19X4, respectively, when measured at Sample Ambulatory Care, Inc's established rates.

8. Concentrations of Credit Risk

[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample
Hospital.]
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